REVIEW article

Front. Neural Circuits, 26 May 2022

Volume 16 - 2022 | https://doi.org/10.3389/fncir.2022.886302

Advancements in the Quest to Map, Monitor, and Manipulate Neural Circuitry

  • 1. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States

  • 2. Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX, United States

  • 3. Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States

  • 4. Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, United States

Article metrics

View details

32

Citations

9,6k

Views

3,5k

Downloads

Abstract

Neural circuits and the cells that comprise them represent the functional units of the brain. Circuits relay and process sensory information, maintain homeostasis, drive behaviors, and facilitate cognitive functions such as learning and memory. Creating a functionally-precise map of the mammalian brain requires anatomically tracing neural circuits, monitoring their activity patterns, and manipulating their activity to infer function. Advancements in cell-type-specific genetic tools allow interrogation of neural circuits with increased precision. This review provides a broad overview of recombination-based and activity-driven genetic targeting approaches, contemporary viral tracing strategies, electrophysiological recording methods, newly developed calcium, and voltage indicators, and neurotransmitter/neuropeptide biosensors currently being used to investigate circuit architecture and function. Finally, it discusses methods for acute or chronic manipulation of neural activity, including genetically-targeted cellular ablation, optogenetics, chemogenetics, and over-expression of ion channels. With this ever-evolving genetic toolbox, scientists are continuing to probe neural circuits with increasing resolution, elucidating the structure and function of the incredibly complex mammalian brain.

Introduction

Neural circuits are the functional building blocks of the brain, comprised of the unique inputs and outputs of connected sets of neurons with particular functions. Nodes within circuits are the keystone checkpoints of neural circuits. In other words, nodes represent anatomically and functionally distinct ensembles of cells that integrate and process neural information from many different inputs to dictate the output of that circuit. These complex networks of connectivity are responsible for everything from processing sensory information (Lohse et al., 2020), attaching valence to stimuli that drive motivated behaviors (Reynolds and Berridge, 2002; Root et al., 2014; Al-Hasani et al., 2015), maintaining physiological homeostasis (Atasoy et al., 2012; Madden and Morrison, 2019), learning, and consolidating memories (Ruder et al., 2021; Sharpe et al., 2021).

Initially, studies of the brain relied on gross anatomy, defining large structures at relatively low resolution, without knowledge of cell type (Scoville and Milner, 1957). Coarsely targeted lesions using electrical current or chemicals allowed researchers to impart functional significance to these anatomically distinct brain regions (Foster et al., 2003; Lavond and Steinmetz, 2003). Early studies also used dyes and microscopy to identify and trace neurons, characterize their morphology, and identify connectivity patterns within discrete brain regions (Golgi, 1886). Electrophysiology was used to classify different neurons by their electrical signature, and to record their inputs and outputs (Piccolino, 1997). Additionally, early electron microscopy experiments provided subcellular resolution of synaptic structures, affording an unparalleled but somewhat myopic view of the brain (Gray, 1959). Although groundbreaking in their time, these applications were limited due to their lack of cell-type specificity, and the constraints of static analysis due to the need to harvest tissue.

One of the continued challenges in neural systems research is dissecting circuit function despite incredible interconnectivity. Many neural circuits have multiple, and often redundant, functions. Adding to this complexity, each node within a circuit has numerous inputs and outputs, as well as feedback and feedforward patterns of interconnectivity. For example, in early lesion studies, it was found that the hypothalamus appeared to affect appetite and body weight (Cushing, 1932; Brobeck, 1946; Brooks et al., 1946; Stellar, 1953; King, 2006). As this circuit was dissected further, it was revealed that two molecularly defined cell types (AgRP/NPY and POMC neurons) appeared to work in opposition to each other to drive either appetite or satiation, respectively (Luquet et al., 2005; Aponte et al., 2011; Zhan et al., 2013). Further studies uncovered that these cells express different receptors with different input and output targets and that POMC neurons are even inhibited locally by AgRP neurons (Sohn, 2014; Sternson and Atasoy, 2014; Wang et al., 2015). Currently, it is now appreciated that this circuit influences diverse behaviors outside the scope of feeding, including locomotion and foraging (Huang et al., 2013; Dietrich et al., 2015). Additionally, numerous non-hypothalamic nodes are sufficient and necessary for normal appetite and body weight control, including regions such as the basal forebrain, amygdala, and dorsal raphe nucleus (Campos et al., 2016; Herman et al., 2016; Kim J. et al., 2017; Patel et al., 2019; Bond et al., 2020; Bruschetta et al., 2020; Ye et al., 2022). This example highlights the complexity of the functional circuitry underlying behaviors such as feeding. As the questions regarding neural circuit structure and function become progressively sophisticated, the tools used to answer them must also evolve.

Fortunately, the toolbox for interrogating neural circuits has expanded rapidly. More precise intersectional genetic approaches have allowed interrogation of circuits with higher resolution and greater cell-type specificity. Additionally, it is now feasible to label groups of neurons based on activity patterns rather than just molecular markers, which may reveal more information about functional ensembles within neural circuits. This review will highlight cell-type-specific tools for targeting neural circuits, which enable more precise (1) mapping and tracing, (2) dynamic monitoring of neural circuit activity, and (3) targeted manipulation of neural circuits via loss- or gain-of-function strategies to infer function (Figure 1). Foremost, intersectional genetic tools and activity-dependent recombinases are used to target molecularly- or activity-defined neuronal populations. These genetic approaches are fundamental for performing any mapping, monitoring, or manipulation experiment with cell type-specificity. Secondly, with advancements in viral tracing strategies, it is now commonplace to map monosynaptic inputs and outputs of circuit nodes with cell type-specificity. This review will describe the contemporary approaches being used for such labeling strategies. Thirdly, it is critical to monitor neural circuit activity to better correlate function. Advancements in activity recording methods, such as genetically encoded calcium and voltage indicators and neurotransmitter sensors, provide new avenues toward understanding how neural circuits function in awake, behaving animals. Finally, causally interrogating neural circuit function via targeted activation or inhibition of select neurons within that circuit lends critical insight into function. Toward this, increasingly sophisticated tools allow investigators to activate and inhibit neural circuits with approaches that include genetically-targeted cell ablation, chemogenetics, and optogenetics. Neuroscientists still have much to learn about the brain, but with these advancements in the ability to map, monitor, and manipulate neural activity, the field of systems neuroscience is in the midst of an intellectual renaissance.

FIGURE 1

Genetic Approaches Toward Achieving Cell-Type Specificity: Site-Specific Recombination, Intersectional Genetics, and Activity-Based Targeting

Historically, brain circuits were investigated using tools that lacked cell type-specificity, such as lesions, pharmacology, and dyes. While this provided critical information about connectivity and function, we now know that each node in the brain is comprised of heterogeneous cell types, whose roles may be functionally distinct. Defining the neuronal constituents that contribute to circuit output is paramount to understanding brain architecture and function (McCulloch and Pitts, 1943). Thus, developing methods to label neurons in a molecularly- or activity-selective manner is imperative.

Site-Specific Recombination and Intersectional Genetics

Neuronal subtypes have been best defined and manipulated by their unique gene expression profiles (Colosimo et al., 2004; Gray et al., 2004; Baumgardt et al., 2007; Flames and Hobert, 2009; Winden et al., 2009). This has partially been made possible through the discovery and creative implementation of site-specific recombination (SSR). SSR affords the ability to selectively target neurons via controlled expression of Cre- and Flp-recombinases (Figure 2A; Dymecki, 1996; Dymecki and Tomasiewicz, 1998; Chai et al., 2000; Awatramani et al., 2003; Branda and Dymecki, 2004; Gong et al., 2007; Anastassiadis et al., 2009; Meinke et al., 2016). Such recombinases can be utilized to excise, invert, or conditionally express genes of interest via the “Lox-Stop-Lox” (LSL), “FRT-Stop-FRT” (Kuhlman and Huang, 2008), or “double-inverted orientation” [DIO; FLEx or FLEx (FRT)] methods (Atasoy et al., 2008; Schwarz et al., 2015). Of these, the DIO approach has proved extremely useful when paired with viral vectors to conditionally express genetic reporters or actuators in a region- or cell-type-specific manner. Additional recombinase/sequence pairs have recently been engineered to expand such approaches, including Dre/rox, VCre/VloxP, and SCre/SloxP (Anastassiadis et al., 2009; Suzuki and Nakayama, 2011). Similar to the Cre/lox system, these pairs can be used to delete, invert, and conditionally express genes of interest depending on the relative orientation of the rox, VloxP, or SloxP sites.

FIGURE 2

In cases where a neuronal population of interest lacks a single unifying molecular marker, multiple pairs of recombinases and sequences can be combined in an intersectional manner (Figure 2B). The Lox and FRT sites in these systems are oriented such that a gene will only be expressed in cells that express both Flp and Cre (for example, Frt-Stop-Frt followed by a FLEXed gene of interest; Dymecki et al., 2002; Awatramani et al., 2003). To reduce the possibility of leaky reporter expression due to stop codon read-through, an alternative intersectional strategy involves placing Lox and FRT sites at intronic sequences that divide a gene of interest, allowing for tighter control of gene expression. Moreover, intronically engineered sites and their adjacent exons can be oriented to facilitate genetic alterations only in cells that express both recombinases (ex. Cre-On, Flp-On or “COn-FOn”; Figure 2B), only one recombinase but not the other (ex. Cre-On/Flp-Off or Cre-Off/Flp-On), or in all cells except those that express both recombinases (ex. Cre-Off/Flp-Off; Fenno et al., 2014, 2020). Additionally, three-factor-dependent constructs have been generated (ex. Cre-On/Flp-On/VCre-On) to achieve even tighter genetic targeting control (Fenno et al., 2020). Such intersectional strategies also allow for the combination of spatially-restricted and cell type-specific drivers for genetic targeting. For example, using a retrogradely-transported Flp (Tervo et al., 2016) in combination with a cell type-specific Cre driver endows the ability to target cells that express a specific marker and project to a defined anatomical location [as in Rossi et al. (2021)].

While many experiments require the use of transgenic approaches to trace circuits or express actuators, engineering transgenic mice can be time-consuming, costly, and have limited experimental applications. The advent of viral genetics to express conditional genetic constructs (via the DIO or similar method) allows one to perform virtually any experiment in a cell type of interest if a Cre-driver is available (Haggerty et al., 2020; Nectow and Nestler, 2020). Viruses also provide better spatial control when targeting specific brain regions. Adeno-associated viruses (AAVs) are the most commonly used viruses in neuroscience. The simplicity of genomic structure, ease of packaging, and relatively non-pathogenic nature have made engineered AAVs ideal for genetic tracking, activity monitoring, and neuromodulation (Saleeba et al., 2019). Moreover, AAVs have selective tropism endowed by their capsid protein, which can be tailored for tissue of interest. For example, capsids such as AAV DJ/8, 2, and 9 are readily used for brain-specific expression (Haggerty et al., 2020; Nectow and Nestler, 2020). Due to the vast experimental possibilities brought about by viral genetics, teasing apart circuit function has been limited largely by the availability of recombinase-based genetic drivers that specify given cell populations. However, the advent of single-cell RNA sequencing is rapidly expanding to reveal potential gene candidates whose expression may serve as reliable and precise markers of different neuronal populations (Zeisel et al., 2015; Gokce et al., 2016; Chen et al., 2017b; Saunders et al., 2018; Tepe et al., 2018; Rossi et al., 2019; Hashikawa et al., 2020; Wallace et al., 2020). This novel information will provide a much larger repertoire of recombinase-expressing driver mice, a critical tool in the age of viral genetics.

Activity-Dependent Methods for Accessing Neuronal Ensembles

In some instances, single genes – or even sets of genes – are unable to adequately characterize the function of neuronal populations, which may operate as molecularly heterogeneous ensembles. Therefore, it is sometimes desirable to characterize neurons in an activity-dependent rather than a genetically-dependent manner. To this end, elegant methods have recently been developed to target neuronal populations based on their activity (DeNardo and Luo, 2017). These methods co-opt immediate-early genes such as Fos (Greenberg and Ziff, 1984) and Arc (Lyford et al., 1995) to drive recombinase expression in active neuronal populations.

Targeted Recombination in Active Populations (TRAP; Guenthner et al., 2013; DeNardo and Luo, 2017) is one such technology in which a tamoxifen-inducible Cre-ER(T2), has been inserted downstream of a Fos promoter. In the presence of tamoxifen, active cellular populations expressing Fos, and therefore Cre-ER(T2), permit translocation of Cre recombinase to the nucleus to facilitate the expression of a Cre-dependent reporter (Guenthner et al., 2013). Similar models exist that use Arc to drive Cre-ER(T2) expression (Guenthner et al., 2013; Figure 2C). A variation of this technology, termed the Tet-tag system, uses a tetracycline transactivator domain downstream of the Fos promoter (Reijmers et al., 2007). In this approach, tetracycline-controlled transactivator protein (tTA) binds to the tetracycline responsive promoter element (TRE) to drive gene expression. In the presence of tetracycline, tTA cannot bind the TRE, and target gene expression is dampened. To use this system, tetracycline must be continually supplied in chow. Upon cessation of tetracycline provision, active neurons produce tTA, allowing the transcription of downstream reporters in a temporally-precise and activity-dependent manner (Reijmers et al., 2007).

One of the major limitations of both the TRAP and Tet-tag systems is the potential for the temporal lag in accurately capturing real-time neuronal activation. Since TRAP relies on the systemic administration of tamoxifen (or similar analogs), active neurons may be labeled throughout a 24-h time window. Similarly, due to the slow time course of tTA activation following the removal of doxycycline, the Tet-Off system also captures cells over extended times (Reijmers et al., 2007; Guenthner et al., 2013). Thus, more temporally precise labeling methods have been sought-after. One such method called “CANE” (capturing neuronal ensembles) utilizes a transgenic mouse expressing destabilized avian-specific receptor TVA under the control of the Fos promoter (Fos-2A-dsTVA; Sakurai et al., 2016). The dsTVA is fused with a degradation signal so that TVA closely mirrors Fos expression patterns. Upon delivery of pseudotyped lentivirus or rabies virus, neurons actively expressing Fos may be tagged for tracing or manipulation experiments (Sakurai et al., 2016). Other methods that tag activated cells based on calcium signals rather than immediate early gene expression and drug delivery have been shown to be even more temporally constrained. For example, CaMPARI, a photoconvertible genetically encoded calcium indicator, labels neurons only when both calcium levels are high and light is delivered to cells, identifying activated neurons on the millisecond timescale with spatial precision (Fosque et al., 2015). Similarly, FLiCRE (Fast Light and Calcium-Regulated Expression) is a method that labels activated cells at the transcriptional level (Kim et al., 2020; Figure 2D). It not only tags activated cells following a calcium influx but also enables the direct manipulation of the tagged cells via the concomitant light-induced expression of Cre. Collectively, these novel activity-driven targeting approaches allow researchers to screen for neural circuits underlying behaviors of interest. This is useful when a molecular marker for a region/behavior is not known, or when more than one molecular marker may contribute to a particular behavior.

Mapping Neural Circuits: Viral and Multiplex Neural Tracing Strategies to Dissect Circuit Anatomy

One of the primary objectives in neural circuit research is to create maps that label neurons within a node, as well as their inputs and outputs. These maps are a critical first step toward understanding circuit function, providing information on cellular morphology, and ultimately, informing the creation of a brain-wide connectome. Initially, circuits were traced in a non-cell type-specific manner with small organic compounds or dyes. These conventional tracers – including lectins (PHA-L; Gerfen and Sawchenko, 1984) and dextran-amines (DAs; Gimlich and Braun, 1985) allowed researchers to label the neuronal membrane, visualizing the soma along with its axonal projections. Other compounds were discovered to label a neuron in a retrograde fashion, being taken up by axon terminals and transported to the soma of a neuron. Such compounds included Horseradish peroxidase (HRP; Kristensson and Olsson, 1971; Kristensson, 1977), Cholera toxin subunit B (CTB; Stoeckel et al., 1977), hydroxystilbamidine (FluoroGold™; Köbbert et al., 2000), and retrobeads (Katz et al., 1984; Katz and Larovici, 1990). Although conventional tracers robustly label neurons and provide glimpses into their complex morphology, they are not sufficient to reveal patterns of connectivity between molecularly defined cell types. As a result, viruses – which enable cell type-specificity and transsynaptic labeling – have largely replaced many conventional tracing methods.

Viral Tracers

Viruses provide many advantages over conventional tracers. Foremost, viral tracers may be engineered as conditional vectors compatible with diverse genetic markers, permitting cell type-specificity. Second, diverse promoters with varying strengths can be used to modulate expression levels or drive cell type-specificity. Lastly, viruses can be engineered to cross single synapses (Kuypers and Ugolini, 1990; Xu et al., 2020). Delivery of viral vectors using stereotaxic injections affords both temporal and spatial specificity, while also obviating the need to generate transgenic mouse models for genetic labeling experiments, so long as the recombinase driver of choice already exists. The following will give an overview of viruses used for both retrograde and anterograde labeling of neural circuits (Table 1).

TABLE 1


NameGenome typeOnset (transport)DurationTranssynaptic labelingToxicity
AnterogradeHSV-129dsDNAHoursMice die 3–5 days after injectionYes (Monosynaptic: H129-ΔTK-tdT)H129-ΔTK-tdT causes toxicity in 3–5 days
AAV1, AAV9ssDNA2–3 weeksMonthsYes (AAV1 is transsynaptic in GABAergic/
glutamatergic neurons)
Minimal
CTBBy 24 h1–2 monthsNoMinimal
PHA-L1–3 weeksSeveral weeksNoMinimal
DAs (10 kda)6–14 daysSeveral weeksNoMinimal
WGA/WGA-HRP3–4 daysYesMinimal
RetrogradeHSVdsDNAHoursUsually 5–7 daysYesDependent on strain and replication competence
Pseudorabies virusdsDNA2–3 weeksMonthsYesDependent on strain and replication competence
CAV-2dsDNA3–7 daysMonthsNoLimited
Rabies virusssRNAAbout 2 daysMonthsYes (Monosynaptic: RABV)Dependent on strain and replication competence
AAV2-retrossDNA1–2 weeksMonthsNoMinimal
CTBBy 24 h1–2 monthsNoMinimal
FluoroGold7–10 daysMonthsNoMinimal
DAs (3 kDa)10–15 daysSeveral weeksNoMinimal
WGA/WGA-HRP3–4 days (WGA-HRP is more sensitive)YesMinimal
HRP5–7 days (Slightly longer than WGA-HRP)NoMinimal

Properties of commonly used conventional (white) and viral neural tracers (blue).

Retrograde Viral Tracers

Retrograde viral tracers label inputs into designated populations of neurons (Figure 3A). HSV-1 was one of the first neurotropic viruses used to transfer genes into specific brain regions via stereotaxic injection (Carlezon et al., 1997; Lilley et al., 2001). While favoring retrograde transport, its ability to travel both anterograde and across the synapse rendered this virus limited in its utility (Ugolini, 2010). Thus, viruses that exclusively travel either retrogradely or anterogradely were sought. This led to the adoption of Pseudorabies (PRV; a misnomer since the virus actually belongs to the herpes virus family) and Rabies virus (RV; Martin and Dolivo, 1983; Ugolini, 1995; Enquist, 2002).

FIGURE 3

Since their discovery, PRV and RV have been widely used to infect the CNS of rodents and non-human primates for retrograde, transsynaptic labeling (Kuypers and Ugolini, 1990; Xu et al., 2020). However, results from these initial experiments proved challenging to interpret, as monosynaptic versus polysynaptic inputs were not discernable. Additionally, viral toxicity caused cell death. To address this problem, pseudotyped RV (RABV) was engineered to label the monosynaptic inputs of genetically and anatomically defined populations (Wickersham et al., 2007). This engineered RABV has a deletion of the endogenous envelope glycoprotein (RG), which is required for viral assembly and transsynaptic transport. By selectively supplying RG in trans to source-cells, RABV can replicate and cross one synapse, but no further. Furthermore, pseudotyping RABV with the avian leucosis virus coat protein EnvA restricts RABV to infect neurons that express the cognate TVA receptor, endowing greater control with cell type-specificity (Etessami et al., 2000; Arenkiel, 2011; Figure 3B). Using this approach, it is possible to trace different cell types within the same brain region, quantifying and comparing mapped inputs between targeted source cell types (Do et al., 2016).

Other types of viruses are also capable of revealing monosynaptic inputs to a node of interest. These retrograde viral tracers include canine adenovirus and modified capsids of AAV. Unlike the rabies virus, these viruses are not transsynaptic. Canine adenovirus type 2 (CAV-2) has high neuronal specificity and selectively infects axon terminals of neurons instead of the soma and dendrites, which makes it a powerful tool for mapping inputs to various brain regions (Soudais et al., 2001; Lavoie and Liu, 2020). For example, the use of CAV-2-Cre in conjunction with Cre-dependent fluorescent reporters allows for efficient mapping to targeted neuronal populations (as in Herman et al., 2016). Also, recent advances in AAV capsid engineering endow directionality-specific transduction. Of these, the rAAV2-retro capsid drives retrograde transport of AAV similar to CAV-2, being taken up by synaptic terminals and transported to the soma of the transduced neuron (Tervo et al., 2016). However, one caveat to both retro-AAVs and CAVs is that they may exhibit selective tropisms. For example, some studies have shown that CAV-2 more efficiently transduces certain neuronal populations compared to retro-AAV (Kakava-Georgiadou et al., 2019), while others have shown that retro-AAV is more efficient than CAV-2 for other neuronal populations (Tervo et al., 2016). Thus, potential biases in tropism may somewhat limit the utility of these viruses in certain brain regions or for targeting different cell types.

Anterograde Viral Tracers

In addition to mapping the inputs, it is also critical to map circuit node outputs, informing the next step in the wiring diagram. Many fluorescent markers labeling either the cytosol or neuronal membrane will label axon terminals, however, it may be difficult to differentiate axon terminals from fibers of passage using these markers (Figure 4A; Xu et al., 2020). A better way to perform anterograde viral tracing is to tag synaptic vesicle proteins with fluorescent markers. For example, synaptophysin::GFP selectively labels presynaptic axon terminals (Li et al., 2010). By conditionally expressing these fusion proteins, one may trace projections in a cell-type-specific manner (Figure 4B). However, close appositions visualized from synaptophysin tracing do not necessarily demonstrate functional synapses (Saleeba et al., 2019). Thus, functional connectivity studies must be performed to validate these projections, as described later in the review. Alternatively, GFP Reconstitution Across Synaptic Partners (GRASP) is a method to visualize anatomically-defined synaptic connections (Feinberg et al., 2008). GRASP relies on the targeted expression of complementary GFP fragments tethered to plasma membrane carrier proteins to detect the proximity of two cells. When two cells form functional synapses, split-GFP fragments reconstitute a functional, fluorescent GFP molecule at the point of contact, labeling the synapse (Feinberg et al., 2008; Kim et al., 2011). For example, when AAV-expressing pre-GRASP was targeted to the auditory cortex and post-GRASP to the inferior colliculus, it was revealed that these two regions are synaptically connected, as indicated by GFP puncta at the point of contact (Song et al., 2018).

FIGURE 4

Several other tools exist for transsynaptic anterograde mapping. Although most of the HSV-1 families are known to spread selectively in the retrograde direction, the H129 strain moves in the anterograde direction, crossing synapses to downstream target cells (Dix et al., 1983; Zemanick et al., 1991; Wojaczynski et al., 2015). Recently, a modified version of H129, H129-ΔTK-tdT, was developed for monosynaptic anterograde tracing. This genetically modified H129 virus has a deletion in the thymidine kinase (TK) gene that is replaced by a tdTomato reporter. Without TK, the H129 virus cannot replicate in neurons, but supplementation of TK from a helper virus allows H129-ΔTK-tdT to spread polysynaptically, labeling post-synaptic target neurons (Lo and Anderson, 2011; Zeng et al., 2017; Figure 4C). In a recent study, AAV-TK-GFP was stereotaxically targeted to the posteromedial thalamic nucleus (VPM) of wild-type mice, and H129-ΔTK-tdT was delivered 21 days later. Post-synaptic tdTomato was observed in cortical layer IV of the visual cortex (V1), revealing a novel connection from the VPM to V1 (Zeng et al., 2017). A polysynaptic version of H129 (H129-G4) has binary tandemly-connected GFP cassettes inserted into the H129 genome, allowing this variant to move anterogradely in a polysynaptic manner with robust labeling capable of revealing intricate neuronal morphologies (Zeng et al., 2017). However, since H129-G4 demonstrates polysynaptic spread, it may be difficult to discern the direct outputs of a particular node. Finally, capsid engineering has also produced AAVs capable of transsynaptic anterograde tracing. AAV1 is a novel capsid that endows preferential transport to postsynaptic neurons (Zingg et al., 2020). However, while AAV1 transsynaptically spreads in both glutamatergic and GABAergic neurons, it does not spread to neuromodulatory cell types, limiting its utility (Zingg et al., 2020).

Multiplexed Mapping Methods

Mapping neural circuits using fluorescent reporters combined with confocal microscopy remains a powerful method for navigating the brain. However, to identify connectivity with single-cell resolution, multiplexed mapping and sequencing approaches have evolved (Figure 5). For example, MAPseq (multiplexed analysis of projections by sequencing) and BRICseq (brain-wide individual animal connectome sequencing) are capable of surveying thousands of neurons in a single experiment (Kebschull et al., 2016; Han et al., 2018; Huang et al., 2020). These approaches utilize the Recombinant Sindbis virus, which rapidly achieves very high expression levels, to express unique mRNA barcodes in individual source cells. These barcodes spread throughout each source cell, including its axonal projections. Both the source area and downstream projections are then micro-dissected, dissociated, and sequenced. After sequencing, barcodes from projection areas are matched to the source area to reveal singe-cell projection patterns (Sun et al., 2021; Figures 5A,B). Recently, Gergues et al. (2020) used MAPseq to map projections from the ventral hippocampus (vHPC). They labeled vHPC neurons with a library of random RNA barcodes, examined 7 different target brain regions, and differentiated projection-specific populations of vHPC neurons (Gergues et al., 2020). One caveat with MAPseq/BRICseq is that the precise positions of individual cell bodies are lost due to tissue dissociation. To overcome this limitation, BARseq (barcoded anatomy resolved by sequencing), combines MAPseq with in situ sequencing to maintain cellular spatial localization (Chen et al., 2018, 2019; Figure 5C). BARseq has been applied to map projections from the mouse auditory cortex to 11 areas of the whole brain, confirming the laminar organization of the three top classes of projection neurons in the auditory cortex (Chen et al., 2019).

FIGURE 5

Other multiplexed mapping methods identify inputs through retrograde transport of barcodes. One such approach is Connect-seq, which determines the molecular identities of individual upstream neurons in a defined circuit by combining retrograde viral tracing and single-cell transcriptomics (Hanchate et al., 2020). Implementing this strategy, Hanchate et al., successfully targeted Cre-dependent PRV infection to corticotropin-releasing hormone neurons within the paraventricular nucleus of the hypothalamus (PVN). Flow cytometry was then used to isolate the upstream inputs, and single-cell RNA-sequencing (scRNA-seq) was used to determine the identities of these inputs (Hanchate et al., 2020). In a similar way, RABID-Seq utilizes pseudotyped rabies virus to label and deliver barcodes to presynaptic inputs in a cell type-specific manner, which may then be identified through scRNA-seq (Clark et al., 2021). Toward this, RABID-Seq has been used to identify axon guidance molecules as mediators of microglia-astrocyte interactions that promote CNS pathologies (Clark et al., 2021; Figure 5D).

In summary, these multiplexed input and output mapping approaches provide unprecedented resolution in the creation of accurate wiring diagrams, providing transcriptomic analyses that are lacking in other contemporary viral tracing approaches.

Clearing Methods for Whole-Brain Neural Circuit Mapping

As neural tracing strategies have evolved, so too have the microscopes and imaging technologies necessary to visualize them. A major obstacle to visualizing deep brain tissue is signal distortion due to light scattering and spherical aberrations. Consequently, imaging long-range projections were effectively impossible. To mitigate these challenges, emerging optical techniques such as CUBIC (Susaki et al., 2014; Murakami et al., 2018; Matsumoto et al., 2019), CLARITY (Chung et al., 2013; Tomer et al., 2014), ScaleS (Hama et al., 2011, 2015), and SeeDB (see deep brain; Ke et al., 2016) “clear” brain tissue. By removing lipids in whole-brain tissue while leaving proteins and nucleic acids intact, tissue effectively becomes transparent, allowing one to image three-dimensional brain architecture or brain-wide neural projections with minimal light scattering. When used in combination with light-sheet microscopy or similar imaging platforms, intricate circuit networks may be visualized in three dimensions, across the entire brain (Newmaster et al., 2021).

Monitoring Neural Circuits: Measuring Circuit Dynamics Via Electrophysiology and Genetically-Encoded Imaging Techniques

Once a circuit has been mapped, observing and quantifying circuit activity is necessary to better understand its function. Monitoring circuit activity using both traditional ex vivo and more recent in vivo methodologies provides information on circuit connectivity and action potential dynamics and correlates circuit function with a particular behavior, sensory perception, or cognitive task. One of the first methods for monitoring circuit activity was recording the electrical activity in the nerve tissue of a dissected frog leg Galvani (Piccolino, 1998). This discovery led to the birth of electrophysiology – the study of the intrinsic electrical properties of cells (Rubaiy, 2017). Electrophysiological techniques record activity dynamics with single-cell resolution, but they are relatively low-throughput in nature. Additionally, while neuron firing patterns can be used to classify certain cell types post hoc, these methods overall lack cell type-specificity. Recent advances have increased the throughput and cell type-specificity of electrical recordings. Furthermore, optical approaches, including genetically-encoded calcium/voltage indicators and neurotransmitter/neuropeptide sensors, have gained incredible momentum.

Electrophysiology

Classical electrophysiology centers around the “patch-clamp” technique, which creates a tight seal on a cell’s membrane using a glass electrode or micropipette to record membrane voltage or current (Neher and Sakmann, 1976). Patch clamping has remained the gold standard of electrophysiology for decades, allowing scientists to measure the properties of ion flow across the membrane and investigate the types of ion channels that regulate the electrical activity of cells. However, recent advancements in patch-clamp configuration allow increased flexibility and greater throughput recordings including cell-attached, inside-out, outside-out, perforated patch, and notably, the whole-cell configuration (Hill and Stephens, 2021).

In an increasingly multimodal research world, electrophysiology has adapted to interface with other sophisticated techniques, allowing users to measure multiple dimensions of neural activity. For example, patch-clamp electrophysiology has been combined with RNA sequencing in a technique known as Patch-Seq. Patch-Seq permits the collection of transcriptomic data after performing whole-cell electrophysiology recordings, as patched cells are drawn into a glass capillary and used for single-cell RNA sequencing (Bardy et al., 2016; Cadwell et al., 2016; Chen et al., 2016; Földy et al., 2016; Fuzik et al., 2016; Lipovsek et al., 2021). Using Patch-Seq, both neuronal activity and gene expression patterns are revealed with single-cell resolution. Indeed, this technique has been used to describe the diversity of neuronal subtypes within the mouse motor cortex, as well as to provide insights into the diversity of neuronal populations in the dorsal striatum (Muñoz-Manchado et al., 2018; Gouwens et al., 2020; Scala et al., 2021).

While recording the electrical properties of single cells has been critical for understanding the basic properties of individual neurons, interrogating the activity of interconnected circuits requires recording from multiple cells simultaneously. Toward this, extracellular recordings using wire or silicon-based electrodes measure action potentials in multiple parallel neurons. By using multiple geometrically arranged electrodes, or multielectrode arrays (MEAs), it is now possible to record many neurons simultaneously from one probe and analyze their summed electrical activity, or local field potentials (LFPs; Buzsáki, 2004; Einevoll et al., 2013). The past decade has seen the rise of increasingly powerful MEAs such as Neuropixels, a silicon-based probe with up to thousands of independent channels for recording hundreds of neurons simultaneously (Jun et al., 2017). With the advent of these new high-throughput recording methods, it is now possible to interrogate the electrical and synaptic properties of circuits with unprecedented spatiotemporal resolution (Csicsvari et al., 2003; Shobe et al., 2015; Jun et al., 2017).

Genetically-Encoded Calcium Indicators

Electrophysiology is optimized to measure the activity of neurons with high temporal precision but is limited in its ability to spatially localize the cells being recorded, or to identify their molecular cell type. With the advent of real-time neural activity imaging, activity-dependent fluorescent reporters have been developed to measure circuit dynamics with high spatial resolution in living brain tissue. Genetically Encoded Calcium Indicators (GECIs) are the most widely used activity-dependent fluorescent reporters. GECIs are proteins that bind cytosolic calcium and exhibit increased fluorescence with calcium influx, a proxy for neuronal firing, thereby translating neural activity into spatially resolved optical signals (Bootman and Berridge, 1995; Miyawaki et al., 1997; Oh et al., 2019). Since fluorescent activity reporters are genetically encoded, their expression can be targeted to specific populations through conditional viral or transgenic methods (Pérez Koldenkova and Nagai, 2013). While the temporal dynamics are less precise than electrophysiological techniques, advancements in imaging resolution and GECI sensitivity enable monitoring of diverse firing dynamics at high spatiotemporal resolution. Importantly, such imaging approaches facilitate the investigation of firing and anatomical properties of neuronal circuits from diverse brain structures, from the cortex to deep brain nuclei (Hoogland et al., 2009).

GCaMP reporters are currently one of the most widely used families of GECIs (Table 2). Structurally, GCaMP is a fusion protein between GFP, calmodulin (a calcium-binding protein), and the light chain myosin protein, which was rationally designed to facilitate increased GFP fluorescence with the influx and binding of free calcium (Shimomura et al., 1962; Porumb et al., 1994; Tallini et al., 2006; Akerboom et al., 2009). Additional improvements to GECI technology have been made via large-scale random mutagenesis (GECOs; Table 3), or semi-rational mutation strategies (GCaMP5 family) to identify indicators with stronger fluorescence intensity, varied activity kinetics (GCaMP6s-f), and greater dynamic ranges (Zhao et al., 2011; Akerboom et al., 2012; Helassa et al., 2015). Notably, GCaMP6 and GCaMP8 are widely used for their fast kinetics, stability, and high signal intensity. GCaMP8 has a higher signal intensity than GCaMP6, making it well suited for experiments to monitor population activity signals via imaging of the soma, while GCaMP6 is preferred for visualizing activity at dendritic spines (Ohkura et al., 2012a).

TABLE 2

ClassIndicatorEmission wavelength (nm)DescriptionReferences
GFPGCaMP1.3/1.6510Slow kinetics for calcium binding; unable to resolve single APs.Nakai et al., 2001; Ohkura et al., 2005; Reiff et al., 2005; Hendel et al., 2008
GCaMP2511Slow kinetics for calcium binding; unable to resolve single APs.Tallini et al., 2006; Hendel et al., 2008
GCaMP3513Adequate fluorescence at basal cell [Ca2+]. Unable to resolve single action potentials (APs) in vivo.Tian et al., 2009; Akerboom et al., 2013; Redolfi et al., 2021
GCaMP5A/D/G/K/L510Improved dynamic range (increased threefold from GCaMP3). Variants can be chosen according to their properties to fit particular experimental requirements.Akerboom et al., 2012; Redolfi et al., 2021
GCaMP6f/m/s510Able to detect single APs. 6f has shortest half-decay time. Variants can be chosen according to their properties to fit experimental requirements. Adequate for imaging experiments over multiple weeks.
Adequate fluorescence at basal cell [Ca2+].
Chen et al., 2013; Rose et al., 2014; Redolfi et al., 2021
jGCaMP7515Enhanced signal-to-noise ratio allows detection of individual spikes over wide fields of view (jGCaMP7s,f). Used for imaging of small processes thanks to the enhanced brightness (jGCaMP7b).Dana et al., 2019; Redolfi et al., 2021
jGCaMP8∼510Enhanced signal intensity, similar kinetics to GCaMP6. Well suited for bulk population recordings.Ohkura et al., 2012b; Redolfi et al., 2021
RFPRCaMP1a630Brighter than RGECO, but lower calcium binding affinity and dynamic range. Not activated by blue light, making it suitable for use with optogenetics.Akerboom et al., 2013; Dana et al., 2016
RCaMP1.07584Higher fluorescence than RGECO. Well suited for use with optogenetics.Ohkura et al., 2012a
RCaMP2583Strong single AP responses, very fast kinetics, suited for dual color calcium imaging with green fluorescent indicators.Inoue et al., 2015
Multiple color variantsXCaMPblue, green, yellow, redImproved signal linearity. Adequate fluorescence at basal cell [Ca2+] (XCaMP-G). Enables measurement of fast-spike trains in individual neurons.Inoue et al., 2019; Redolfi et al., 2021

Commonly used GCaMP reporters.

TABLE 3

ClassIndicatorEmission wavelength (nm)DescriptionReferences
GECOG-GECO1-1.2∼512Better than GCaMP3 for monitoring spontaneous Ca2 + oscillations. Higher fluorescence than GCaMP3. pH-sensitive.Zhao et al., 2011
B-GECO1446Suited for multichromatic imaging. pH-insensitive compared to G-GECOs. Interference with mitochondrial autofluorescence.Zhao et al., 2011
R-GECO1∼600Greater dynamic range and higher calcium binding affinity than RCaMP. Susceptible to artifact-induced excitation with blue and green light.Zhao et al., 2011; Akerboom et al., 2013
NIR-GECO2/2G685/40Near-infrared calcium indicators susceptible to infrared light-induced activation. Lower brightness and slower kinetics than standard green and red GECIs.Qian et al., 2020
GEX-GECO1∼510Fast kinetics, large dynamic range.Zhao et al., 2011
GEM-GECO1511/455Good signal range, mitochondrial autofluorescence does not interfere with its activity.Zhao et al., 2011
jRGECO1a630Faster than RCaMP.Dana et al., 2016
CamgaroosCamgaroo-1513Unable to detect single APs. Exhibits slower kinetics than latest GCaMP versions.Baird et al., 1999; Barth, 2007
Camgaroo-2535Unable to detect single APs. Exhibits slower kinetics than latest GCaMP versions.Griesbeck et al., 2001; Barth, 2007

Non-GCaMP-based genetically encoded calcium indicators, including GECOs and camgaroos.

In parallel with the continued development of diverse fluorescent indicator proteins, imaging technologies have also advanced. Classical GECI recordings were often made in superficial brain areas due to the relative ease of access for optical observation. The development of miniaturized fiber optic-based photometry has facilitated studying deep-brain structures in awake, behaving animals in real-time (Helmchen et al., 2001; Grewe et al., 2010; Lütcke et al., 2010). However, fiber photometry measures bulk calcium dynamics, lacking cellular resolution. Now, experiments using implantable gradient refractive index (GRIN) lenses combined with mini-microscopes or 2-photon interfaces permit real-time dynamic recordings from individual cells deep within the brain (Helmchen et al., 2001; Barretto et al., 2009; Ghosh et al., 2011; Zong et al., 2017; Zhang et al., 2019). GECIs represent a powerful tool for monitoring the activity of neural circuits in a cell type-specific manner. This highly optimized and titratable system has revolutionized the field of systems neuroscience, allowing for bulk activity recordings and spike extractions from big data sets such as the Machine Intelligence from Cortical Networks (MICrONS) data set, which contains large scale tracing and functional connectivity data obtained through electron microscopy (Zhou et al., 2020). The combination of highly optimized calcium indicators, genetic targeting technology, sophisticated imaging techniques, and big data analysis through machine learning approaches have opened the door for an in-depth, mechanistic understanding of circuit dynamics with unprecedented precision.

Genetically-Encoded Voltage Indicators

While GECIs remains an invaluable tool to study cell-type-specific circuit dynamics, due to their dependence on calcium activity they represent an indirect measure of cell activity. The development of genetically encoded voltage indicators (GEVIs) directly measures neuronal activity, as indicated by neuronal membrane potential, in a more temporally precise manner than calcium indicators (Table 4). Although the advent of GEVIs predates GECIs until recently, circuit monitoring via GEVIs has suffered from limitations in imaging technologies and available voltage indicators. Advancements in image processing and GEVI development have paved the way for the visualization of voltage dynamics in genetically defined circuits (Chamberland et al., 2017). The first GEVIs were designed as fusion proteins between GFP and voltage-sensing domains (VSDs) like those found in voltage-gated ion channels (Siegel and Isacoff, 1997; Sakai et al., 2001; Dimitrov et al., 2007). Within the class of VSD-based GEVIs, two main families of indicators have been categorized by the number of fluorescent proteins fused to the VSD: FRET GEVIs (also known as ratiometric GEVIs) and single fluorescent protein (monochromatic) GEVIs.

TABLE 4

ClassIndicatorFluorescence reporter (Emission wavelength nm)DescriptionReferences
Ion Channel-FPsShaker Kv-based FlaSHFLaSH-GFP (505)Slow, cannot resolve APs. Potential co-assembly with native channel subunits. Low fluorescence change.Jin et al., 2011; Kostyuk et al., 2019
SPARCGFP (505)Faster than FLaSH-based sensors, reports pulses as low as 2ms. Does not inactivate during extended depolarizations. Low fluorescence change.Ataka and Pieribone, 2002; Kostyuk et al., 2019
FlaSH with split FPDepends on FPLow fluorescence change; slow kinetics.Jin et al., 2011
FRETVSFP1/2s, CRCFP (477)
YFP (529)
citrine (529)
Reliable membrane targeting. Limited by slower response kinetics compared to VSFP butterflies.Sakai et al., 2001; Dimitrov et al., 2007; Lundby et al., 2008; Mutoh et al., 2009; Lam et al., 2012; Mishina et al., 2014
Chimeric VSFP butterfliesCitrine (542)
mKate2 (594)
Faster than previous VSFPs. Reports membrane voltage oscillations up to 200 Hz.Mishina et al., 2014
NabiNabi1: mKO (559), UKG (499); Nabi2: Clover (515), mRuby2 (600)Better SNR, faster than VSFP butterflies and VSFP-CR.Sung et al., 2015
Mono-chromatic FPsVSFP3sCitrine (529) mOrange (562) TagRFP (584) mKate2 (633)VSFP3 faster than VSFP2.3. Red-shifted VSFP3 available.Lundby et al., 2008; Perron et al., 2009
ArclightGFP (507)Robustly reports AP and subthreshold events and reveals electrical signals in neurite branches.Cao et al., 2013; Borden et al., 2017
Bongwooris.e.pHluorin A227D (509)Faster kinetics than Arclight. Resolves 60 Hz APs.Piao et al., 2015
CpFP-based VSFPsDepends on the FPWeaker fluorescence than red shifted indicators. However, the red shifted indicators are still slower and weaker compared to other VSFPs.Gautam et al., 2009
FlicRcpmApple (560)Bright and fast-read voltage indicator. Brighter than ArcLight Q239, similar kinetics to ArcLight Q239.Abdelfattah et al., 2016
ASAP familyCpGFP (509)ASAP1 has on-off kinetics of ∼2ms, detects APs and subthreshold changes. Tracks AP trains up to 200 Hz. ASAP2 more sensitive, suited for 2p imaging.St-Pierre et al., 2014; Chamberland et al., 2017
Rhodopsin fluorescent probesArchArch (687nm), Arch (D95N; 687nm)Fast and sensitive voltage sensor but it is very dim.Kralj et al., 2011
QuasArsQuasAr1 (H95Q) 715 nmBoth QuasAr1 and QuasAr2 have enhanced fluorescence compared to Arch (D95N).Hochbaum et al., 2014
ArchonsArchon 1 retinal cofactor (637 nm)Archon1 follows small, high-speed voltage changes in cultured neurons; brighter than QuasArsPiatkevich et al., 2018
Opsin/FRETAce-mNeonmNeonGreen (517 nm)Responds five to six times as fast as MacQ-mCitrine and ASAP1 indicator; more photostable.Gong et al., 2015
VARNAMMRuby3 N81S (565 nm)Resolves APs with sensitivity and kinetics comparable to Ace-mNeon.Kannan et al., 2018
MacQ-m CitirinemCitirine (529nm)Faster kinetics than Arclight. Not brighter than Arclight but with a comparable or better SNR.Gong et al., 2014
QuasAr2-mOrange2Retinal cofactor (715 nm)Outperforms red-shifted ASAP1 and eFRET GEVIs in sensitivity, speed, SNR and photostability, but requires intense laser illumination.Zou et al., 2014
Fret-DyeVoltronJF525 (532 nm)Brighter than Ace2N-mNeon and ASAP2f in cell culture. Improved photostability compared to Ace2N-mNeon. In mice, allows single-trial recording of spikes and subthreshold voltage signals from dozens of neurons simultaneously for 15 min.Abdelfattah et al., 2019
OtherhVOSEGFP-F + DPA (505 nm)Improved sensitivity and temporal resolution compared to previous GFP based probes.Chanda et al., 2005
VoltageSpy(546 nm)Robust, single-trial optical detection of APs at soma. Reports APs in axons and dendrites.Grenier et al., 2019

Commonly used GEVIs.

AP, action potential; SNR, signal-to-noise ratio. Knöpfel and Song (2019).

Ratiometric GEVIs use voltage-dependent Förster resonance energy transfer (FRET) to modify the conformation of the VSD, in turn changing the conformation of two fluorescent proteins such that the readout is an anticorrelated switch from fluorescence in one color to another. FRET GEVIs are particularly useful for circuit monitoring applications in vivo, where the anticorrelated color-switching can be parsed out from hemodynamic correlated changes in fluorescents within the same color (Akemann et al., 2012, 2010). Monochromatic GEVIs, on the other hand, contain a single fluorescent protein that emits a single wavelength of light, best suited for cell culture or slice preparation experiments. The advantage of this kind of GEVI is that the optical imaging setup required for measuring its activity is less complex than that of the ratiometric GEVI. However, given that there is only a single wavelength emitted, performing in vivo imaging requires more complex corrective methods to account for hemodynamic changes and/or a multiplexed approach (Borden et al., 2017).

One of the major limitations of VSD-based GEVIs is the weak signal-to-noise ratio. Thus, a second major class of GEVIs was developed based on naturally occurring microbial opsins. These GEVIs take advantage of the native fluorescence of these opsins, but also amplify this signal by binding them to brighter fluorescent proteins, thus reducing the effect of photobleaching that is seen in other GEVIs (Isobe et al., 1983; Adam et al., 2019; Piatkevich et al., 2019). For example, FRET-opsins have been developed that couple rhodopsin to another fluorescent protein, such that the fast dynamics of the opsin can be coupled to the brightness of the additional fluorescent protein for better signal-to-noise ratios. Fluorescent proteins such as yellow mCitrine, the bright green mNeonGreen, or the orange mRuby3 and mScarlet, have been used to generate MacQ-mCitrine, Ace-mNeonGreen, VARNAM, and Ace-mScarlet, respectively (Gong et al., 2014, 2015; Gong, 2015; Kannan et al., 2018; Beck and Gong, 2019; Mollinedo-Gajate et al., 2021). These opsin-based GEVIs have been leveraged in the study of circuit dynamics in cell culture, slice preparations, and in vivo experiments within cerebellar Purkinje cells (Gong, 2015).

Förster resonance energy transfer-opsins represent an advancement in the design of GEVIs to overcome signal-to-noise limitations. However, due to a greater molecular size, they are susceptible to forming intracellular aggregates that impede their localization to the cell plasma membrane (Hochbaum et al., 2014; Kannan et al., 2019). To circumvent this limitation, a new class of chemigenetic hybrid GEVIs has been developed that consists of two components – the first which targets the indicator to a cell type of interest, while the fluorescent protein is separately delivered to the target tissue, often intravenously (Sundukova et al., 2019). Within the class of chemigenetic GEVIs, three main families of indicators exist: Opsin-Dye FRET chemigenetic indicators, fluorescent protein-dye FRET hybrid indicators, and indicators that use photo-induced electron transfer. The two most promising opsin-dye FRET chemigenetic indicators are Voltron and Positron – both of which use a microbial opsin fused to a self-labeling protein tag that allows for the binding of a fluorescent protein (Grimm et al., 2015; Abdelfattah et al., 2019, Abdelfattah et al., 2020). Fluorescent protein-dye FRET indicators use an exogenous chromophore coupled to a fluorescent protein, where the chromophore is used to quench fluorescence based on cell membrane voltage (Chanda et al., 2005; Wang et al., 2010). Lastly, photo-induced electron transfer GEVIs work using a voltage-sensitive fluorescent protein-tagged to the SpyTag protein which covalently binds to the SpyCatcher membrane protein in the cell (Grenier et al., 2019). Voltage sensing is achieved by photo-induced electron transfer through a synthetic wire in the membrane that reversibly quenches the activity of the fluorescent protein (Mollinedo-Gajate et al., 2021). The ability to target GEVI expression with cell-type specificity and improved membrane localization allows for greater reliability and precision in the quest to measure circuit dynamics.

Although fluorescent protein-based GEVIs represent a powerful way to measure neural activity, these indicators are limited in their photostability and potential for toxicity at high expression levels. A class of bioluminescent GEVIs has recently been developed that overcomes these limitations (Inagaki et al., 2019, 2017). Bioluminescent GEVIs provide cells with a substrate that can be converted into a fluorescent reporter based on changes in membrane potential. Traditional bioluminescent GEVIs combine a VSD, luciferase, and a fluorescent protein in a similar configuration to FRET-based GEVIs, whereby voltage changes produce a FRET-based anticorrelated signal between the luciferase and fluorescent reporter. While the anticorrelated design allows for better signal-to-noise ratios, it is limited by the requirement of the exogenous substrate, luciferin. To overcome this limitation, recent advancements have been made such that the bioluminescent GEVI self-generates an energy-rich substrate for light-emitting activity (Srinivasan et al., 2019; Mollinedo-Gajate et al., 2021).

While voltage indicator technology has advanced greatly in recent years, continued improvements to their photostability, signal intensity, and power of imaging platforms are required in order to more readily compete with calcium indicators (Yang and St-Pierre, 2016). However, new and improved GEVIs are continually being engineered to address these concerns, providing direct monitoring of electrical activity in living cells. Despite the high signal intensity provided by GECIs, this tool can only provide binary information on whether a neuron is active, lacking the temporal dynamics required to accurately determine neuronal firing patterns. Additionally, GECIs rely on indirect measures of neuronal activity via calcium. In contrast, GEVIs provide the necessary kinetics to accurately portray complex firing patterns, and even signal propagation throughout an individual neuron, but lack the appropriate signal intensity to generate high-quality data. A paradigm shift in the use of GECIs versus GEVIs may come in the future, but this requires continued advancements in both imaging techniques and protein engineering to improve GEVIs.

Neurotransmitter and Neuropeptide Sensors

Electrophysiology, GECIs, and GEVIs reveal detailed neuronal activity, and with the power of viral and transgenic targeting technologies, interrogate circuit dynamics with cell-type specificity. However, these techniques are limited in their ability to measure cell-cell communication dynamics at the synapse. To study the real-time communications between active neurons, novel protein-based sensors that bind to and report the release of neurotransmitters have emerged, providing an unprecedented view of the dynamics of communication between neurons (Table 5).

TABLE 5

SensorExcitation/Emission wavelengths (nm)Detection rangeON kinetics (ms)Applications in vivoReferences
Glutamate sensors
iGluSnFR490/5101 μM–10 mM15C. elegans, zebrafish, mouseMarvin et al., 2013; Helassa et al., 2018; Helassa et al., 2018
SF-iGluSnFR-A184S490/5101 μM–10 mM85Mouse, ferretMarvin et al., 2018
iGluu490/51010 μM–10 mM0.7N/A(Helassa et al., 2018
SF-Venus-iGluSnFR515/5281 μM–10 mMN/AMouseMarvin et al., 2018
R-iGluSnFR1562/5881 μM–10 mMN/AN/AWu et al., 2018
GABA sensor
iGABASnFR485/5101 μM–10 mM∼25Zebrafish, mouseMarvin et al., 2019
Cholinergic sensors
iAchSnFR485/5100.1–100 μM∼25Zebrafish, mouse, C. elegans, DrosophilaBorden et al., 2020
iNicSnFR485/5351 μM–10 mM∼1000ZebrafishShivange et al., 2019
GACh3.0492/5100.1–100 μM312Mouse, DrosophilaJing et al., 2020
Serotonin sensors
iSeroSnFR490/512330 pM–5 mM0.5MouseUnger et al., 2020
sLight1.3490/5161 nM–10 μMN/AMousePatriarchi et al., 2018
GRAB5–HT490/5101 nM–1 μM200MouseWan et al., 2021
Dopamine sensors
dLight1.1490/51610 nM–10 μM10MousePatriarchi et al., 2018
dLight1.2490/51610 nM–10 uM9.5MousePatriarchi et al., 2018
dLight1.3b490/516100 nM–100 μMN/AMouse, ratPatriarchi et al., 2018
dLight1.4490/5161 nM–1 μMN/AMouse, ratPatriarchi et al., 2018
GRABDA1m490/51010 nM–1 μM80Mouse, Drosophila, zebrafishSun et al., 2018
GRABDA1h490/5101 nM–10 μM110Mouse, Drosophila, zebrafishSun et al., 2018
R-dLight1562/5880.01–100 μM14Mouse, ratPatriarchi et al., 2020
Norepinephrine sensors
nLight1.3490/5160.1–100 μMN/AMouseOe et al., 2020
GRABNE1m490/5100.1–100 μM72Mouse, zebrafishFeng et al., 2019
Orexin sensors
OxLight1470/5600.1–10 μM500–700MouseDuffet et al., 2022
Oxytocin sensors
MTRIAOT490/5100.01–1 μM12,000MouseIno et al., 2021
GRABOT1.0490/5100.001–1 μM500MouseQian et al., 2022

Properties and applications of genetically encoded neurotransmitter sensors.

Neurotransmitter sensors come in two main classes – periplasmic binding protein (PBP)-based sensors and G-protein coupled receptor (GPCR)-based sensors. PBP-based sensors use microbial PBPs fused to fluorescent proteins to report the presence of neurotransmitters in the synaptic cleft. One of the first PBP-based sensors developed was iGluSnFR, which has been used to detect glutamate in vitro and in vivo in mice, worms, and zebrafish (Marvin et al., 2013). Since then, advanced versions of iGluSnFR with different color and kinetic properties have been developed. Other sensors in the PBP class of neurotransmitter sensors include iGABASnFR, iAChSnFR, and iSeroSnFR, as well as small molecule sensors like iATPSnFR, and iNicSnFR (Lobas et al., 2019; Marvin et al., 2019; Shivange et al., 2019; Borden et al., 2020; Unger et al., 2020). One caveat to using PBP-based sensors is that since they are microbially based, they may interfere with endogenous cellular processes and machinery.

GPCR-based sensors overcome this limitation, as they mimic the properties of endogenous receptors and are quite stable. GPCR sensors bind to neurotransmitters present in the synapse and cause a conformational change that results in a fluorescent signal. Some of the neurotransmitter sensors in this class include the dLight1 and GRABDA families of dopaminergic sensors as well as the GRABNE, GRAB5–HT, and GRABACh sensors for norepinephrine, serotonin, and acetylcholine, respectively (Jing et al., 2018; Patriarchi et al., 2018; Sun et al., 2018; Feng et al., 2019; Wan et al., 2021). Furthermore, the advent of neuropeptide GPCR-based sensors such as OxLight1, MTRIAOT, and GRABOT1.0 for orexin and oxytocin, respectively, permits the visualization of volume transmission from dendrites as well as axon terminals (Ino et al., 2021; Duffet et al., 2022; Qian et al., 2022). However, due to competitive interference from endogenous receptors, the readout of neurotransmitter activity using GPCR sensors will necessarily be based on the relative change in fluorescence rather than the absolute number of neurotransmitter molecules present at the synapse. Additionally, GPCR-based sensors cannot be used for pharmacological studies as they will interfere with the drug-receptor interactions. Thus, depending on the application, either PBP or GPCR sensors may be preferred.

The development of neurotransmitter sensors heralds a new era of neuroscientific discovery, where cell-cell neuronal communication is not only capable of being monitored at the cellular level, but at the synapse itself. In fact, biosensors are even being developed to monitor the activity patterns of second messengers downstream of synaptic transmission (Tewson et al., 2016; Massengill et al., 2021). For example, recent studies using a cAMP biosensor revealed that dopamine-triggered cAMP release in the basal amygdala facilitates learning (Lutas et al., 2022). With the advent of these sensors, neurotransmitter and signaling cascade dynamics may be studied to understand how these molecules play a role in the development and function of circuit architecture within the brain. Additionally, when used in tandem with GECIs or GEVIs, one may monitor both neural activity and neural signaling dynamics at once.

Manipulating Neural Circuits: Gain-And Loss-Of-Function Approaches Toward Interrogating Circuit Function

Mapping circuit connectivity and monitoring its activity patterns reveal critical knowledge regarding brain anatomy and function. However, monitoring a circuit even with cell-type-specific genetic tools only provides correlative data on circuit function. To test hypotheses, researchers often implement gain- or loss-of-function experimentation. About 200 years ago, through post-mortem observation of diseased patients, Dr. Broca identified a lesioned area in the left frontal cortex of an individual that contributed to speech production, as this patient had speech defects (Broca, 1861). While lesioning may still be used in neural systems research, the ability to draw correlations between brain structure and function has accelerated substantially in the last several decades due to the advent of genetically targeted gain- or loss-of-function strategies. Activating a circuit or node reveals its sufficiency to drive a particular phenotype. Reciprocally, inhibiting a circuit or node reveals whether it is necessary for a particular phenotype. Redundant and interdependent circuits add a layer of complexity to these experiments, as they may reveal a circuit to be only sufficient, only necessary, or both toward a particular phenotype. Recent advances in targeted genetic approaches have dramatically improved our ability to manipulate circuits with greater genetic, spatial, and temporal specificity.

Targeted Ablation

Although electrolytic or chemical lesioning methods remain powerful techniques to interrogate structure and function relationships in the brain (Foster et al., 2003; Lavond and Steinmetz, 2003), these approaches are non-specific, ablating all the cells in a given area. Alternatively, genetically-targeted ablation may be used for cell type-specific lesioning. One such system was adopted from the bacteria Corynebacterium diphtheriae. Its earliest rendition involved the use of transgenic lines that placed a diphtheria toxin (DT) gene under a promoter of interest (Breitman et al., 1987; Saito et al., 2001). Cells that used this promoter would express DT, driving their own death. The principal limitation of this technology was that the timing of cellular ablation could not be controlled. Since ablating cells early in development may result in compensatory plasticity mechanisms, it became desirable to temporally control ablation. In 2001, these limitations were abrogated by controlling cellular expression of the DT receptor (DTR), which is not endogenously expressed in the mouse. In this way, the experimenter could selectively express DTR in specific cell types, and provide exogenous DT at any point in development to selectively ablate cells expressing DTR (Saito et al., 2001). This technology led to the discovery that AgRP/NPY neurons are required for proper feeding behaviors in adult mice, but are not required in neonate mice, perhaps due to compensatory mechanisms (Luquet et al., 2005). One important consideration with cellular ablation is that it is permanent. Other experiments may require reversible manipulation, such as the techniques discussed below.

Pharmacology

Neuronal activity can be manipulated by specific chemicals. Commonly, this is due to agonistic or antagonistic effects on neural ion channels (Narahashi et al., 1964; Collingridge et al., 1983; Sweeney et al., 1995; Verderio et al., 1999; Corcoran and Quirk, 2007). By infusing pharmacological substances in particular brain regions, it is readily possible to investigate the effect of activating or inhibiting targeted areas. One common means of drug delivery is through a stereotaxically implanted hollow cannula (Sike et al., 2017). This can be combined with other technologies such as microdialysis or in vivo imaging to dissect the effects of drug treatments on neurotransmitter release, neural activity, and gene expression. Commonly used pharmacologically active chemicals used to manipulate neuronal activity are summarized in Table 6. Importantly, pharmacological manipulations are specific to cells that express a particular receptor but are not selective in the cell types they may target. For reversible and cell type-specific manipulation experiments, opto- or chemogenetics have proven invaluable.

TABLE 6

CompoundDescriptionReferences
Tetrodotoxin (TTX)Puffer fish-derived chemical that selectively blocks voltage gated sodium channels most associated with the action potential. Most useful in electrophysiologic confirmation of a monosynaptic connection between neurons. In vivo it can also be used to inhibit brain regions through cannulation.Narahashi et al., 1964
APVBlocks the NMDA glutamate receptor. It has been critical in understanding both long term depression and potentiation.Collingridge et al., 1983
CNQXA stable and selective blocker of AMPA receptors, drawn from a broad class of engineered compounds known as quinoxalinediones.Corcoran and Quirk, 2007
Tetanus toxinA bacterially derived protein that can inhibit SNARE mediated exocytosis, thereby inhibiting neurotransmission. In 1995, this technology was made to be expressed directly by neurons, paving the way for current cell-type specific vesicular release silencing.Sweeney et al., 1995; Verderio et al., 1999

Commonly used pharmacological agents in neural circuit studies.

Optogenetics

In the late 1970s, Francis Crick remarked that the real challenge of neuroscience would be to precisely control the activity of a desired set of neurons. Nearly three decades later, George Nagel, Peter Hegemann, and colleagues discovered Channelrhodopsin-2 (ChR2), a light-gated cation channel that demonstrated inward cationic current with millisecond time-scale resolution (Nagel et al., 2003). Shortly after this discovery, Boyden, Deisseroth, and colleagues showed that ChR2 could be leveraged to manipulate the activity of neurons using light in a technique known as optogenetics (Boyden et al., 2005). Currently, it remains one of the most temporally and spatially specific methodologies to manipulate neural activity, both ex vivo and in vivo, in which mice are implanted with fiber optics for light delivery (Yizhar et al., 2011). Optogenetics has led to many systems-level discoveries, such as the solidification of arcuate hypothalamic feeding circuitry. In this study, conditional expression of ChR2 and subsequent activation of AgRP cells in the arcuate nucleus of the hypothalamus led to robust acute food consumption, while optogenetic activation of POMC neurons led to decreased food consumption (Aponte et al., 2011).

At the core of optogenetics is the use of opsins. Upon photon absorption, opsins undergo a conformational change that allows for ion transport across the plasma membrane, either depolarizing or hyperpolarizing neurons (Foster and Bellingham, 2002). As described in Table 7, a plethora of opsins has been engineered that allow great flexibility in their experimental use. These opsins have attributes that differ in terms of effects on membrane potential, kinetics, and absorption spectra (Yizhar et al., 2011; Deisseroth, 2015). Furthermore, more than one type of opsin can be expressed by cells. For example, an excitatory opsin activated by blue light (e.g., ChR2) can be co-expressed with an inhibitory opsin activated by yellow light (e.g., halorhodopsin; Han and Boyden, 2007). This allows for either gain- or loss-of-function experimentation within the same animal. Another consideration in the design of an optogenetic experiment is the location of the light source, either at the soma or axon terminals of the opsin-expressing neural population. If placed at the soma, those cells and all of their projection targets will be affected (Figure 6A). If placed at the axon terminals, only that projection site will be affected (Yizhar et al., 2011; Figure 6B). The latter approach allows for greater dissection of the exact circuitry involved in a particular phenotype (Steinberg et al., 2014). Interestingly, stimulating somata versus terminal fields can result in disparate phenotypes. For example, one study used opsins to stimulate or inhibit basolateral amygdala (BLA) projections to the central amygdala, which altered anxiety-related behaviors, while stimulating BLA cell bodies had no effect. This was perhaps due to downstream projections operating in opposition to each other (Tye et al., 2011). Thus, terminal field stimulation is very useful for dissecting circuit function, as cells may have diverse collateralizations.

TABLE 7

EffectVariantDescription of opsinPeak activation wavelength (nm)References
Excitatory (de-polarizing)ChR2Most widely used cation conducing opsin, non-specific cation channel from Chlamydomonas reinhardtii470Boyden et al., 2005
ChR/T159C and ChR2/H134Mutations in ChR2 that induce relatively larger photocurrents.450, 470Lin et al., 2009; Berndt et al., 2011
ReaChRRed-shifted variant of ChR2.590Lin et al., 2013
ChETA (E123T)ChR2 mutations that induce more rapid kinetics, at the cost of smaller photocurrents.490Lin, 2011
SFO/SSFOStep-opsins with delayed closing of ion channel for sustained action (current will continue upon cessation of light); quickly closes with red-light pulse.470 (closed with 590)Berndt et al., 2009
ChrimsonRRed-shifted variant of ChR2.590Klapoetke et al., 2014
C1C2GABlue-shifted microbial opsin-based variant.455Kato et al., 2015
Inhibitory (hyper-polarizing)Halorhodopsin (eNph3.0)Light-gated chloride channel found in halobacteria. Red-shifted, improved trafficking to membrane.589Gradinaru et al., 2010
Archaerhodopsins (eArch3.0, eArchT 3.0)Light gated proton pump from Halobrum. ArchT 3.0 has enhanced trafficking to membrane and light sensitivity.566Mattis et al., 2011
JawsRed shifted cruxhalorhodopsin from Haloarcula; acts as a chloride pump.632Chuong et al., 2014
SwiChR(CA)A mutated chimera of ChR that acts as a chloride-conducting anion channel; delayed off-kinetics rapidly corrected by brief red light pulse475Berndt et al., 2014
iChlocCMutant of ChR that permits chloride conduction with high selectivity and sensitivity476Wietek et al., 2015
GtACR1, 2, and ZipACR1Light-gated chloride channels from Guillardia thetaACR1: 515
ACR2: 470
Zip: 520
Govorunova et al., 2015, 2017
AuroraEngineered anion-conducting channelrhodopsin; Red-shifted, with step-function capabilities517Wietek et al., 2017
Dual color actuatorsBiPOLESDual color controller of neuronal activity that allows for excitation or inhibition based on photostimulation wavelength.Inhibition: 490
Excitation: 635
Vierock et al., 2021

Opsins are commonly used in optogenetics with their salient properties.

FIGURE 6

However, it must be considered that the nature of optogenetics frequently necessitates a level of invasiveness that may be unacceptable. For example, very deep brain regions with functions essential to survival may not be compatible with external light delivery (Chen et al., 2021). Further, the tethering required by most light-delivery systems may compromise the validity of certain behavioral experiments (Won et al., 2020). Finally, light delivery may lead to tissue toxicity, for example, due to heating or ischemia (Chen et al., 2017a). Therefore, at times less invasive means may be needed to manipulate neural circuits transiently, which is possible through chemogenetics.

Chemogenetics

Chemogenetics refers to a set of techniques whereby genetically engineered receptors expressed on cell surfaces bind to exogenously delivered ligands. Importantly, these ligands are not endogenously produced. Early examples of chemogenetic technologies came in 1998 with Receptors Activated Solely by a Synthetic Ligand (RASSLs; Conklin et al., 2008). Currently, the most commonly used receptors for manipulations are coupled to G proteins known as DREADDs: Designer Receptors Exclusively Activated by Designer Drugs. DREADDs are activated by the ligand Clozapine-N-Oxide (CNO; Whissell et al., 2016; Table 8). Depending on the receptor’s associated downstream signaling cascade, the ligand may be excitatory (Gq, Gs) and increase cell firing, or inhibitory (Gi) and decrease cell firing. While CNO-activated DREADDs are one of the most widely used tools for chemogenetic neural manipulation, this technology has some major limitations. It has been shown that CNO does not cross the blood-brain barrier, but rather its parent metabolite, clozapine (a known antipsychotic drug), exerts effects in the brain (Gomez et al., 2017). Additionally, clozapine has been shown to bind to endogenous receptors throughout the body at high doses and with known effects on animal behavior (Desloovere et al., 2019). However, these findings remain controversial, as other studies report opposing findings in mice (Guettier et al., 2009; Jendryka et al., 2019). To overcome such limitations, studies have shown that at low doses of clozapine, these off-target effects are reduced (Manvich et al., 2018; Matsui et al., 2018). Additionally, novel ligands like olanzapine, JHU37160/152, and deschloroclozapine are being used for DREADD-based manipulations as they have a minimal conversion to other compounds and less off-target effects (Bonaventura et al., 2019; Weston et al., 2019; Nagai et al., 2020).

TABLE 8

Receptor nameMechanism of actionEffect on neuronal firingLigandReferences
hM3DqPhospholipase C Dependent (activator)IncreasedCNO/clozpine/JHU37152/
JHU37160/deschloroclozapine (DCZ)
Alexander et al., 2009; Gomez et al., 2017; Bonaventura et al., 2019; Nagai et al., 2020
hM1DqPhospholipase C Dependent (activator)IncreasedCNOAlexander et al., 2009
hM5DqPhospholipase C Dependent (activator)IncreasedCNOArmbruster et al., 2007
hM4DiAdenylate Cyclyase Dependent (inhibitor)DecreasedCNO/clozpine/JHU37152/
JHU37160/deschloroclozapine (DCZ)
Zhu et al., 2014; Gomez et al., 2017; Matsui et al., 2018; Bonaventura et al., 2019; Nagai et al., 2020
hM2DiAdenylate Cyclyase Dependent (inhibitor)DecreasedCNOArmbruster et al., 2007
Rq(R165L)B-arrestin dependentunknownCNONakajima and Wess, 2012
KORDAdenylate Cyclyase Dependent (inhibitor)DecreasedSalvinorin BVardy et al., 2015
PSAM-5HT3Ligand gated cation channelIncreasedvariniclineMagnus et al., 2019
PSAM-GlyRLigand gated anion channelDecreasedvariniclineMagnus et al., 2019

Common chemogenetic receptors and ligands with their associated properties and effects on neuronal activity.

Some experiments require one to manipulate several neural populations at once or to bidirectionally control the activity of one neural population. Through a recently developed technology labeled DREADD KORD(R), chemogenetics is afforded the possibility of multiplexing. DREADD KORD(R)s are sensitive to a distinct exogenously delivered ligand known as Salvinorin B and completely insensitive to CNO (Vardy et al., 2015). The non-overlapping pharmacologic activation of DREADD KORD(R) and DREADDs provides superior bidirectional manipulation relative to optogenetics, since opsins may absorb photons at overlapping ranges, potentially confounding results. However, the temporal resolution of DREADD action is less precise than optogenetics and operates on the timescale of minutes to hours (Whissell et al., 2016). This is because it takes time for the synthetic ligand (e.g., CNO) to distribute to areas that express the DREADD, and also because GCPRs have slower kinetics than ion channels. This can be beneficial when requiring more chronic forms of manipulation, but less useful for applications where faster or more temporally-precise manipulations are desired.

While chemogenetics is limited by less precise temporal and spatial resolution, newer technologies are emerging. For example, magnetically-sensitive lipid nanoparticles carrying CNO ensure the steady release of CNO to targeted circuits (Rao et al., 2019). Additionally, it is possible to employ both opsins and DREADDs for bidirectional control of neural activity (Han et al., 2017; Siemian et al., 2021). Alternatively, the development of Pharmacologically Selective Activator Modules (PSAMs) which are activated by Pharmacologically Selective Effector Molecules (PSEMs) increases temporal resolution (Shapiro et al., 2012). Unlike DREADDs which alter neuronal activity through the modulation of GPCR-biased signaling cascades, PSAMs affect neuronal activity through modulation of ligand-gated ion channels. Most recent iterations of the technology use the agonist varenicline, an FDA-approved drug. Although varenicline binds to nicotinic receptors (ligand-gated ion channels), scientists have generated a PSAM that binds to varenicline at a low enough concentration that it will not bind to endogenously produced receptors (Magnus et al., 2019).

Both optogenetic and chemogenetic manipulations allow for controlled activation or inhibition of circuitry in a genetically-defined manner. While useful, these technologies are limited by the need to consistently deliver an actuator (e.g., light through fiber optics for optogenetics or ligands for chemogenetics). Thus, using opto- or chemogenetics for studies in which a circuit would need to be activated/inhibited for more than several hours each day (for example, body weight or metabolism studies) is not optimal. For these studies, it is desirable to chronically activate neural activity, as with the overexpression of exogenous ion channels (Johns et al., 1999; Ren et al., 2001; Lin et al., 2010; Patel et al., 2019; Zhu et al., 2020).

Ion Channel Manipulations: Kir and NaChBac

Neuronal excitability corresponds to a neuron’s likelihood of triggering an action potential. This likelihood is dependent on ion channel expression and functionality. Given the same stimuli, neurons with greater excitability will fire more frequently than neurons with lesser excitability (Hille, 2001). Scientists can bias excitability by manipulating the types and amounts of ion channels expressed on the neuronal plasma membrane so as to shift resting membrane potential (Johns et al., 1999; Lin et al., 2010; Zhu et al., 2020). Since these methods do not require drug administration or photostimulation, they are less invasive measures for studying neural function. However, these methods lack precise on/off control compared to optogenetics or chemogenetics.

One ion channel used to manipulate neural activity chronically is Kir2.1, an inward rectifying potassium channel that makes action potential generation more difficult (Johns et al., 1999). In 2017, the targeted expression of Kir2.1 helped to elucidate a circuit node responsible for integrating social input and modulating aggressive behavioral output (Watanabe et al., 2017). In 2020, the technology was used to understand the arcuate neuronal contribution to feeding behaviors (Zhu et al., 2020). To increase the temporal flexibility of this technology, methods have been devised to temporally control the expression of the channels using ligands or light, or both. For example, SPARK (Synthetic Photoisomerizable Azobene Regulation K + channels) has a genetically engineered K + channel that is sensitive to an exogenously delivered, light-sensitive ligand (Banghart et al., 2004). In the absence of the ligand, the channel remains open and hyperpolarizes the cell. In the presence of the ligand, and the absence of UV light, the K + channel closes. Finally, in the presence of both the ligand and UV light, the channel opens. This affords the flexibility of choosing when to hyperpolarize the cell or allow resting neuron conditions.

Other exogenous ion channels may be used to increase cell excitability and provide gain-of-function approaches. One such channel is the voltage-gated Sodium Bacterial Channel (NaChBac; Ren et al., 2001; Lin et al., 2010). Most importantly, NaChBac opens at more negative voltages relative to eukaryotic sodium channels. Consequently, subthreshold stimuli open these channels, thereby conferring both a greater depolarizing stimulus and an increased probability of action potential generation. Secondly, upon opening, they enable long-lasting depolarizing stimuli that can drive further action potentials. NaChBacs have been used to understand the roles of both corticotropins-releasing hormone (Zhu et al., 2020) and glutamate (Herman et al., 2016; Patel et al., 2019) in modulating feeding behaviors.

Mapping and Monitoring Through Manipulation

Several experimental approaches combine diverse manipulation methods, such as optogenetics, with viral tracing or circuit monitoring techniques. An elegant intersection between circuit mapping, monitoring, and manipulation is the technique known as Channelrhodopsin Assisted Circuit Mapping (CRACM; Petreanu et al., 2007). This technology is a gold standard in the generation of reliable, functional circuit diagrams. Here, opsins and reporters are expressed on a pre-synaptic cell of interest. Then, by taking whole-cell recordings of a putative post-synaptic cell while stimulating the pre-synapse, one may identify synaptic currents on the post-synaptic cell. The temporal coincidence between light stimulation and post-synaptic currents, combined with the application of pharmacological agents that abolish this response, provides strong evidence for a functional synaptic connection between pre- and post-synaptic cells (Petreanu et al., 2009). While CRACM is useful, depending on the circumstance, it can have drawbacks. For example, depending on the expression profile of the opsin, it can be difficult to determine which side of the pre-or post-synapse is being excited by light when an electrophysiological event is being recorded in the post-synaptic cell. This can be mitigated by conditionally expressing the opsin in a neuronal subtype distinct from the post synaptic neuron. Alternatively, one can use an opsin whose expression is spatially restricted to the soma/proximal dendrites (Baker et al., 2016). One other limitation is the challenge of performing CRACM with peptidergic cell types. This is because neuropeptides often signal via volume transmission, which occurs over large distances and with potentially slower effects compared to fast neurotransmitters (like glutamate and GABA; Fuxe et al., 2013; Nederpelt et al., 2016).

Without sophisticated techniques like Patch-Seq, electrophysiology lacks the ability to identify the exact cells being recorded. Combining electrophysiology with optogenetics allows in vivo targeting of genetically labeled cells for electrophysiological recordings through a “sonar”-like method (Lima et al., 2009; Hangya et al., 2015). The development of small implantable optrodes, or electrode(s) juxtaposed to a fiber optic for light delivery, locates conditional ChR2-expressing neurons via optogenetic stimulation in vivo. Once ChR2-expressing cells of interest are located (as indicated by reliable light-induced single units), extracellular recordings assess cellular electrical activity (Figure 7). The “opto-sonar” technique provides a dependable method to genetically identify and target circuits within a live, freely behaving animal. Indeed, with the integration of optogenetics and implantable MEAs, it is now commonplace to not only monitor the activity of genetically defined circuits but manipulate and assess their activity and temporal dynamics in vivo (Kim C. K. et al., 2017).

FIGURE 7

Another emergent multiplexed technology is known as holographic imaging. Holograms are light fields that form any simple and complex shape through wavefront interference. By combining imaging technologies with principles of holography, it has become possible to map, monitor, and manipulate populations of neurons in multiple regions of interest (in different focal planes) with an unprecedented combination of spatial and temporal resolution (Quirin et al., 2014; Yang et al., 2015). In a 2018 paper, Yang and colleagues simultaneously photostimulated 80 neurons within the mouse visual cortex while also monitoring the neighboring neuronal activity (Yang et al., 2018). This technology has since been leveraged to understand how neural ensembles within cortical circuitry can drive recall in a complex behavioral task (Carrillo-Reid et al., 2019). While certain technical limitations to the technology exist (e.g., limited field of view, lag in modulating projected holographic patterns, etc.), more profound challenges present themselves in how the output data is analyzed and interpreted (Carrillo-Reid et al., 2017; Yang and Yuste, 2018). To better use this emergent technology, creating methods to analyze these huge datasets must be a major focus moving forward.

Discussion

The advent of genetic technologies has provided much insight into the complexities of how neural circuits are anatomically and functionally connected. However, dissecting circuits even at the level of molecularly defined groups of neurons may soon be too general. Thus, we expect the future circuit analyses will be done at the level of an individual cell, leveraging omics-based high-throughput approaches to map, monitor, and manipulate neural circuits. For example, while numerous cell-type-specific Cre and Flp drivers have been developed in recent years, continued advances in single-cell sequencing to generate novel drivers, and the use of intersectional and activity-driven genetic labeling techniques may afford the ability to isolate neural subpopulations with greater specificity. Additionally, multiplexed viral tracing techniques strategies that contribute toward maps with greater definition will provide rich anatomical datasets compared to traditional viral tracing or tract labeling methods. Such multiplexed approaches combined with tissue contemporary tissue clearing methods will facilitate the exquisite ability to map individual cells within complex circuits and in three dimensions. Collectively, these methods will rapidly advance the building of comprehensive circuit wiring diagrams with greater resolution.

While electrophysiology will remain a standard for evaluating synaptic connectivity and measuring the electrical properties of individual neurons, novel high-throughput electrophysiology approaches that enable simultaneous recording of hundreds of neurons at once, as with Neuropixels, greatly surpasses current electrophysiology limitations. Additionally, optical approaches for monitoring circuit dynamics will continue to evolve and expand. For example, genetically encoded calcium and voltage indicators, as well as neurotransmitter and neuropeptide sensors, will most likely steadily improve in signal-to-noise, photostability, and kinetics, thus expanding their utility greatly. When used in tandem with GRIN lenses or 2-photon imaging capabilities, genetically encoded imaging experiments can provide a clear picture of the signaling dynamics of individual neurons within dynamic networks. Indeed, the toolbox for circuit activity manipulations will continue to expand as well, with continued advances in optogenetics, chemogenetics, and genetically engineered ion channels with improved temporal, spatial, and cell type precision. With the help of in silico and directed evolution protein engineering methodologies, this will allow a cornucopia of different approaches toward mapping and manipulating neural circuits within living brain tissue.

In the future, multiplexing of a variety of approaches to map, monitor, and manipulate circuits simultaneously will provide more precise experimentation than current methods. However, the major limitations we currently face with these multiplexed, omics-based, and high-throughput methodologies is how these huge datasets will be processed and analyzed in order to make meaningful conclusions about the brain. This will require computation scientists, bioinformaticians, and neuroscientists to work together toward solving these unprecedented problems. Ultimately, better-informed circuit diagrams that link anatomy with the function will provide novel therapeutic targets for numerous neurological diseases, which may include obesity/eating disorders, psychiatric disorders, and neurodegenerative diseases.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Author contributions

JS, P-SC, JR, and SS: conceptualization, writing, editing, and figure and table generation. PH: writing, figure and table generation. JO-G: editing, figure and table generation. BA: conceptualization and editing. All authors contributed to the article and approved the submitted version.

Funding

We would like to thank numerous funding sources that support the BA’s laboratory and its members in the development of the manuscript: Eunice Kennedy Shriver National Institute of Child Health and Human Development (5P50HD103555-02), National Institute of Neurological Disorders and Stroke (5R01NS078294-08 and 1UF1NS111692-01), National Institute of Diabetes and Digestive and Kidney Diseases (3R01DK109934-05S1 and 2R01DK109934-05), and United States Department of Agriculture (158-3092-0-001).

Acknowledgments

Special thanks to the members of the BA’s laboratory for helping with editing the manuscript and providing valuable feedback.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    AbdelfattahA. S.FarhiS. L.ZhaoY.BrinksD.ZouP.RuangkittisakulA.et al (2016). A bright and fast red fluorescent protein voltage indicator that reports neuronal activity in organotypic brain slices.J. Neurosci.3624582472. 10.1523/JNEUROSCI.3484-15.2016

  • 2

    AbdelfattahA. S.KawashimaT.SinghA.NovakO.LiuH.ShuaiY.et al (2019). Bright and photostable chemigenetic indicators for extended in vivo voltage imaging.Science365699704. 10.1126/science.aav6416

  • 3

    AbdelfattahA. S.ValentiR.ZhengJ.WongA.et alGenie Project, Team (2020). A general approach to engineer positive-going eFRET voltage indicators.Nat. Commun.11:3444. 10.1038/s41467-020-17322-1

  • 4

    AdamY.KimJ. J.LouS.ZhaoY.XieM. E.BrinksD.et al (2019). Voltage imaging and optogenetics reveal behaviour-dependent changes in hippocampal dynamics.Nature569413417. 10.1038/s41586-019-1166-7

  • 5

    AkemannW.MutohH.PerronA.ParkY. K.IwamotoY.KnöpfelT. (2012). Imaging neural circuit dynamics with a voltage-sensitive fluorescent protein.J. Neurophysiol.10823232337. 10.1152/jn.00452.2012

  • 6

    AkemannW.MutohH.PerronA.RossierJ.KnöpfelT. (2010). Imaging brain electric signals with genetically targeted voltage-sensitive fluorescent proteins.Nat. Methods7643649. 10.1038/nmeth.1479

  • 7

    AkerboomJ.Carreras CalderónN.TianL.WabnigS.PriggeM.TolöJ.et al (2013). Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics.Front. Mol. Neurosci.6:2. 10.3389/fnmol.2013.00002

  • 8

    AkerboomJ.ChenT.-W.WardillT. J.TianL.MarvinJ. S.MutluS.et al (2012). Optimization of a GCaMP calcium indicator for neural activity imaging.J. Neurosci.321381913840. 10.1523/JNEUROSCI.2601-12.2012

  • 9

    AkerboomJ.RiveraJ. D. V.GuilbeM. M. R.MalavéE. C. A.HernandezH. H.TianL.et al (2009). Crystal structures of the GCaMP calcium sensor reveal the mechanism of fluorescence signal change and aid rational design.J. Biol. Chem.28464556464. 10.1074/jbc.M807657200

  • 10

    AlexanderG. M.RoganS. C.AbbasA. I.ArmbrusterB. N.PeiY.AllenJ. A.et al (2009). Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors.Neuron632739. 10.1016/j.neuron.2009.06.014

  • 11

    Al-HasaniR.McCallJ. G.ShinG.GomezA. M.SchmitzG. P.BernardiJ. M.et al (2015). Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward.Neuron8710631077. 10.1016/j.neuron.2015.08.019

  • 12

    AnastassiadisK.FuJ.PatschC.HuS.WeidlichS.DuerschkeK.et al (2009). Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice.Dis. Model. Mech.2508515. 10.1242/dmm.003087

  • 13

    AponteY.AtasoyD.SternsonS. M. (2011). AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training.Nat. Neurosci.14351355. 10.1038/nn.2739

  • 14

    ArenkielB. R. (2011). Genetic approaches to reveal the connectivity of adult-born neurons.Front. Neurosci.5:48. 10.3389/fnins.2011.00048

  • 15

    ArmbrusterB. N.LiX.PauschM. H.HerlitzeS.RothB. L. (2007). Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.Proc. Natl. Acad. Sci. U.S.A.10451635168. 10.1073/pnas.0700293104

  • 16

    AtakaK.PieriboneV. A. (2002). A genetically targetable fluorescent probe of channel gating with rapid kinetics.Biophys. J.82509516. 10.1016/S0006-3495(02)75415-5

  • 17

    AtasoyD.AponteY.SuH. H.SternsonS. M. (2008). A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping.J. Neurosci.2870257030. 10.1523/JNEUROSCI.1954-08.2008

  • 18

    AtasoyD.BetleyJ. N.SuH. H.SternsonS. M. (2012). Deconstruction of a neural circuit for hunger.Nature488172177. 10.1038/nature11270

  • 19

    AwatramaniR.SorianoP.RodriguezC.MaiJ. J.DymeckiS. M. (2003). Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation.Nat. Genet.357075. 10.1038/ng1228

  • 20

    BairdG. S.ZachariasD. A.TsienR. Y. (1999). Circular permutation and receptor insertion within green fluorescent proteins.Proc. Natl. Acad. Sci. U.S.A.961124111246. 10.1073/pnas.96.20.11241

  • 21

    BakerC. A.ElyadaY. M.ParraA.BoltonM. M. (2016). Cellular resolution circuit mapping with temporal-focused excitation of soma-targeted channelrhodopsin.eLife5:e14193. 10.7554/eLife.14193

  • 22

    BanghartM.BorgesK.IsacoffE.TraunerD.KramerR. H. (2004). Light-activated ion channels for remote control of neuronal firing.Nat. Neurosci.713811386. 10.1038/nn1356

  • 23

    BardyC.van den HurkM.KakaradovB.ErwinJ. A.JaegerB. N.HernandezR. V.et al (2016). Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology.Mol. Psychiatr.2115731588. 10.1038/mp.2016.158

  • 24

    BarrettoR. P. J.MesserschmidtB.SchnitzerM. J. (2009). In vivo fluorescence imaging with high-resolution microlenses.Nat. Methods6511512. 10.1038/nmeth.1339

  • 25

    BarthA. L. (2007). Visualizing circuits and systems using transgenic reporters of neural activity.Curr. Opin. Neurobiol.17567571. 10.1016/j.conb.2007.10.003

  • 26

    BaumgardtM.Miguel-AliagaI.KarlssonD.EkmanH.ThorS. (2007). Specification of neuronal identities by feedforward combinatorial coding.PLoS Biol.5:e37. 10.1371/journal.pbio.0050037

  • 27

    BeckC.GongY. (2019). A high-speed, bright, red fluorescent voltage sensor to detect neural activity.Sci. Rep.9:15878. 10.1038/s41598-019-52370-8

  • 28

    BerndtA.LeeS. Y.RamakrishnanC.DeisserothK. (2014). Structure-guided transformation of channelrhodopsin into a light-activated chloride channel.Science344420424. 10.1126/science.1252367

  • 29

    BerndtA.SchoenenbergerP.MattisJ.TyeK. M.DeisserothK.HegemannP.et al (2011). High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels.Proc. Natl. Acad. Sci. U.S.A.10875957600. 10.1073/pnas.1017210108

  • 30

    BerndtA.YizharO.GunaydinL. A.HegemannP.DeisserothK. (2009). Bi-stable neural state switches.Nat. Neurosci.12229234. 10.1038/nn.2247

  • 31

    BonaventuraJ.EldridgeM. A. G.HuF.GomezJ. L.Sanchez-SotoM.AbramyanA. M.et al (2019). High-potency ligands for DREADD imaging and activation in rodents and monkeys.Nat. Commun.10:4627. 10.1038/s41467-019-12236-z

  • 32

    BondC. W.TrinkoR.FoscueE.FurmanK.GromanS. M.TaylorJ. R.et al (2020). Medial nucleus accumbens projections to the ventral tegmental area control food consumption.J. Neurosci.4047274738. 10.1523/JNEUROSCI.3054-18.2020

  • 33

    BootmanM. D.BerridgeM. J. (1995). The elemental principles of calcium signaling.Cell83675678. 10.1016/0092-8674(95)90179-5

  • 34

    BordenP. M.ZhangP.ShivangeA. V.MarvinJ. S.CichonJ.DanC.et al (2020). A fast genetically encoded fluorescent sensor for faithful in vivo acetylcholine detection in mice, fish, worms and flies.BioRxiv [preprint] 10.1101/2020.02.07.939504

  • 35

    BordenP. Y.OrtizA. D.WaiblingerC.SederbergA. J.MorrissetteA. E.ForestC. R.et al (2017). Genetically expressed voltage sensor ArcLight for imaging large scale cortical activity in the anesthetized and awake mouse.Neurophotonics4:031212. 10.1117/1.NPh.4.3.031212

  • 36

    BoydenE. S.ZhangF.BambergE.NagelG.DeisserothK. (2005). Millisecond-timescale, genetically targeted optical control of neural activity.Nat. Neurosci.812631268. 10.1038/nn1525

  • 37

    BrandaC. S.DymeckiS. M. (2004). Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice.Dev. Cell6728. 10.1016/s1534-5807(03)00399-x

  • 38

    BreitmanM. L.ClapoffS.RossantJ.TsuiL. C.GlodeL. M.MaxwellI. H.et al (1987). Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice.Science23815631565. 10.1126/science.3685993

  • 39

    BrobeckJ. R. (1946). Mechanism of the development of obesity in animals with hypothalamic lesions.Physiol. Rev.26541559. 10.1152/physrev.1946.26.4.541

  • 40

    BrocaP. (1861). Remarques sur le siège de la faculté du langage articulé, suivies d’une observation d’aphémie (perte de la parole).Bull Memoires Soc. anatomique Paris6330357.

  • 41

    BrooksC. M.LockwoodR. A.WigginsM. L. (1946). A study of the effect of hypothalamic lesions on the eating habits of the albino rat.Am. J. Physiol.147735741. 10.1152/ajplegacy.1946.147.4.735

  • 42

    BruschettaG.JinS.LiuZ.-W.KimJ. D.DianoS. (2020). MC4R signaling in dorsal raphe nucleus controls feeding, anxiety, and depression.Cell Rep.33:108267. 10.1016/j.celrep.2020.108267

  • 43

    BuzsákiG. (2004). Large-scale recording of neuronal ensembles.Nat. Neurosci.7446451. 10.1038/nn1233

  • 44

    CadwellC. R.PalasantzaA.JiangX.BerensP.DengQ.YilmazM.et al (2016). Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-seq.Nat. Biotechnol.34199203. 10.1038/nbt.3445

  • 45

    CamposC. A.BowenA. J.SchwartzM. W.PalmiterR. D. (2016). Parabrachial CGRP neurons control meal termination.Cell Metab.23811820. 10.1016/j.cmet.2016.04.006

  • 46

    CaoG.PlatisaJ.PieriboneV. A.RaccugliaD.KunstM.NitabachM. N. (2013). Genetically targeted optical electrophysiology in intact neural circuits.Cell154904913. 10.1016/j.cell.2013.07.027

  • 47

    CarlezonW. A.BoundyV. A.HaileC. N.LaneS. B.KalbR. G.NeveR. L.et al (1997). Sensitization to morphine induced by viral-mediated gene transfer.Science277812814. 10.1126/science.277.5327.812

  • 48

    Carrillo-ReidL.HanS.YangW.AkrouhA.YusteR. (2019). Controlling visually guided behavior by holographic recalling of cortical ensembles.Cell178447.e457.e. 10.1016/j.cell.2019.05.045

  • 49

    Carrillo-ReidL.YangW.Kang MillerJ.-E.PeterkaD. S.YusteR. (2017). Imaging and optically manipulating neuronal ensembles.Annu. Rev. Biophys.46271293. 10.1146/annurev-biophys-070816-033647

  • 50

    ChaiY.JiangX.ItoY.BringasP.HanJ.RowitchD. H.et al (2000). Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis.Development12716711679. 10.1242/dev.127.8.1671

  • 51

    ChamberlandS.YangH. H.PanM. M.EvansS. W.GuanS.ChavarhaM.et al (2017). Fast two-photon imaging of subcellular voltage dynamics in neuronal tissue with genetically encoded indicators.eLife6:e25690. 10.7554/eLife.25690

  • 52

    ChandaB.BlunckR.FariaL. C.SchweizerF. E.ModyI.BezanillaF. (2005). A hybrid approach to measuring electrical activity in genetically specified neurons.Nat. Neurosci.816191626. 10.1038/nn1558

  • 53

    ChenR.CanalesA.AnikeevaP. (2017a). Neural recording and modulation technologies.Nat. Rev. Mater.2:16093. 10.1038/natrevmats.2016.93

  • 54

    ChenR.WuX.JiangL.ZhangY. (2017b). Single-Cell RNA-Seq Reveals Hypothalamic Cell Diversity.Cell Rep.1832273241. 10.1016/j.celrep.2017.03.004

  • 55

    ChenR.GoreF.NguyenQ.-A.RamakrishnanC.PatelS.KimS. H.et al (2021). Deep brain optogenetics without intracranial surgery.Nat. Biotechnol.39161164. 10.1038/s41587-020-0679-9

  • 56

    ChenT.-W.WardillT. J.SunY.PulverS. R.RenningerS. L.BaohanA.et al (2013). Ultrasensitive fluorescent proteins for imaging neuronal activity.Nature499295300. 10.1038/nature12354

  • 57

    ChenX.SunY.-C.ChurchG. M.LeeJ. H.ZadorA. M. (2018). Efficient in situ barcode sequencing using padlock probe-based BaristaSeq.Nucleic Acids Res.46:e22. 10.1093/nar/gkx1206

  • 58

    ChenX.SunY.-C.ZhanH.KebschullJ. M.FischerS.MathoK.et al (2019). High-Throughput Mapping of Long-Range Neuronal Projection Using In Situ Sequencing.Cell179772.e786.e. 10.1016/j.cell.2019.09.023

  • 59

    ChenX.ZhangK.ZhouL.GaoX.WangJ.YaoY.et al (2016). Coupled electrophysiological recording and single cell transcriptome analyses revealed molecular mechanisms underlying neuronal maturation.Protein Cell7175186. 10.1007/s13238-016-0247-8

  • 60

    ChungK.WallaceJ.KimS.-Y.KalyanasundaramS.AndalmanA. S.DavidsonT. J.et al (2013). Structural and molecular interrogation of intact biological systems.Nature497332337. 10.1038/nature12107

  • 61

    ChuongA. S.MiriM. L.BusskampV.MatthewsG. A. C.AckerL. C.SørensenA. T.et al (2014). Noninvasive optical inhibition with a red-shifted microbial rhodopsin.Nat. Neurosci.1711231129. 10.1038/nn.3752

  • 62

    ClarkI. C.Gutiérrez-VázquezC.WheelerM. A.LiZ.RothhammerV.LinnerbauerM.et al (2021). Barcoded viral tracing of single-cell interactions in central nervous system inflammation.Science372:eabf1230. 10.1126/science.abf1230

  • 63

    CollingridgeG. L.KehlS. J.McLennanH. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus.J. Physiol.3343346. 10.1113/jphysiol.1983.sp014478

  • 64

    ColosimoM. E.BrownA.MukhopadhyayS.GabelC.LanjuinA. E.SamuelA. D. T.et al (2004). Identification of thermosensory and olfactory neuron-specific genes via expression profiling of single neuron types.Curr. Biol.1422452251. 10.1016/j.cub.2004.12.030

  • 65

    ConklinB. R.HsiaoE. C.ClaeysenS.DumuisA.SrinivasanS.ForsayethJ. R.et al (2008). Engineering GPCR signaling pathways with RASSLs.Nat. Methods5673678. 10.1038/nmeth.1232

  • 66

    CorcoranK. A.QuirkG. J. (2007). Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears.J. Neurosci.27840844. 10.1523/JNEUROSCI.5327-06.2007

  • 67

    CsicsvariJ.HenzeD. A.JamiesonB.HarrisK. D.SirotaA.BarthóP.et al (2003). Massively parallel recording of unit and local field potentials with silicon-based electrodes.J. Neurophysiol.9013141323. 10.1152/jn.00116.2003

  • 68

    CushingH. (1932). Papers Relating to the Pituitary Body, Hypothalamus and Parasympathetic Nervous System.Springfield, Ill.: C. C. Thomas.

  • 69

    DanaH.MoharB.SunY.NarayanS.GordusA.HassemanJ. P.et al (2016). Sensitive red protein calcium indicators for imaging neural activity.eLife5:e12727. 10.7554/eLife.12727

  • 70

    DanaH.SunY.MoharB.HulseB. K.KerlinA. M.HassemanJ. P.et al (2019). High-performance calcium sensors for imaging activity in neuronal populations and microcompartments.Nat. Methods16649657. 10.1038/s41592-019-0435-6

  • 71

    DeisserothK. (2015). Optogenetics: 10 years of microbial opsins in neuroscience.Nat. Neurosci.1812131225. 10.1038/nn.4091

  • 72

    DeNardoL.LuoL. (2017). Genetic strategies to access activated neurons.Curr. Opin. Neurobiol.45121129. 10.1016/j.conb.2017.05.014

  • 73

    DesloovereJ.BoonP.LarsenL. E.MerckxC.GoossensM.-G.Van den HauteC.et al (2019). Long-term chemogenetic suppression of spontaneous seizures in a mouse model for temporal lobe epilepsy.Epilepsia6023142324. 10.1111/epi.16368

  • 74

    DietrichM. O.ZimmerM. R.BoberJ.HorvathT. L. (2015). Hypothalamic Agrp neurons drive stereotypic behaviors beyond feeding.Cell16012221232. 10.1016/j.cell.2015.02.024

  • 75

    DimitrovD.HeY.MutohH.BakerB. J.CohenL.AkemannW.et al (2007). Engineering and characterization of an enhanced fluorescent protein voltage sensor.PLoS One2:e440. 10.1371/journal.pone.0000440

  • 76

    DixR. D.McKendallR. R.BaringerJ. R. (1983). Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.Infect. Immun.40103112. 10.1128/iai.40.1.103-112.1983

  • 77

    DoJ. P.XuM.LeeS.-H.ChangW.-C.ZhangS.ChungS.et al (2016). Cell type-specific long-range connections of basal forebrain circuit.eLife5e13214. 10.7554/eLife.13214

  • 78

    DuffetL.KosarS.PannielloM.VibertiB.BraceyE.ZychA. D.et al (2022). A genetically encoded sensor for in vivo imaging of orexin neuropeptides.Nat. Methods19231241. 10.1038/s41592-021-01390-2

  • 79

    DymeckiS. M. (1996). A modular set of Flp, FRT and lacZ fusion vectors for manipulating genes by site-specific recombination.Gene171197201. 10.1016/0378-1119(96)00035-2

  • 80

    DymeckiS. M.RodriguezC. I.AwatramaniR. B. (2002). Switching on lineage tracers using site-specific recombination.Methods Mol. Biol.185309334. 10.1385/1-59259-241-4:309

  • 81

    DymeckiS. M.TomasiewiczH. (1998). Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse.Dev. Biol.2015765. 10.1006/dbio.1998.8971

  • 82

    EinevollG. T.KayserC.LogothetisN. K.PanzeriS. (2013). Modelling and analysis of local field potentials for studying the function of cortical circuits.Nat. Rev. Neurosci.14770785. 10.1038/nrn3599

  • 83

    EnquistL. W. (2002). Exploiting circuit-specific spread of pseudorabies virus in the central nervous system: insights to pathogenesis and circuit tracers.J. Infect. Dis.186S209S214. 10.1086/344278

  • 84

    EtessamiR.ConzelmannK.-K.Fadai-GhotbiB.NatelsonB.TsiangH.CeccaldiP.-E. (2000). Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study.J. Gen. Virol.8121472153. 10.1099/0022-1317-81-9-2147

  • 85

    FeinbergE. H.VanhovenM. K.BendeskyA.WangG.FetterR. D.ShenK.et al (2008). GFP Reconstitution Across Synaptic Partners (GRASP) defines cell contacts and synapses in living nervous systems.Neuron57353363. 10.1016/j.neuron.2007.11.030

  • 86

    FengJ.ZhangC.LischinskyJ. E.JingM.ZhouJ.WangH.et al (2019). A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine.Neuron102745.e761.e. 10.1016/j.neuron.2019.02.037

  • 87

    FennoL. E.MattisJ.RamakrishnanC.HyunM.LeeS. Y.HeM.et al (2014). Targeting cells with single vectors using multiple-feature Boolean logic.Nat. Methods11763772. 10.1038/nmeth.2996

  • 88

    FennoL. E.RamakrishnanC.KimY. S.EvansK. E.LoM.VesunaS.et al (2020). Comprehensive Dual- and Triple-Feature Intersectional Single-Vector Delivery of Diverse Functional Payloads to Cells of Behaving Mammals.Neuron107836.e853.e. 10.1016/j.neuron.2020.06.003

  • 89

    FlamesN.HobertO. (2009). Gene regulatory logic of dopamine neuron differentiation.Nature458885889. 10.1038/nature07929

  • 90

    FöldyC.DarmanisS.AotoJ.MalenkaR. C.QuakeS. R.SüdhofT. C. (2016). Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologically defined neurons.Proc. Natl. Acad. Sci. U.S.A.113E5222E5231. 10.1073/pnas.1610155113

  • 91

    FosqueB. F.SunY.DanaH.YangC.-T.OhyamaT.TadrossM. R.et al (2015). Neural circuits. Labeling of active neural circuits in vivo with designed calcium integrators.Science347755760. 10.1126/science.1260922

  • 92

    FosterJ. A.BezinL.GrocL.ChristophersonP. L.LevineR. A. (2003). Kainic acid lesion-induced nigral neuronal death.J. Chem. Neuroanat.266573. 10.1016/S0891-0618(03)00040-1

  • 93

    FosterR.BellinghamJ. (2002). Opsins and melanopsins.Curr. Biol.12R543R544. 10.1016/s0960-9822(02)01047-3

  • 94

    FuxeK.Borroto-EscuelaD. O.Romero-FernandezW.ZhangW.-B.AgnatiL. F. (2013). Volume transmission and its different forms in the central nervous system.Chin. J. Integr. Med.19323329. 10.1007/s11655-013-1455-1

  • 95

    FuzikJ.ZeiselA.MátéZ.CalvigioniD.YanagawaY.SzabóG.et al (2016). Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes.Nat. Biotechnol.34175183. 10.1038/nbt.3443

  • 96

    GautamS. G.PerronA.MutohH.KnöpfelT. (2009). Exploration of fluorescent protein voltage probes based on circularly permuted fluorescent proteins.Front. Neuroeng.2:14. 10.3389/neuro.16.014.2009

  • 97

    GerfenC. R.SawchenkoP. E. (1984). An anterograde neuroanatomical tracing method that shows the detailed morphology of neurons, their axons and terminals: immunohistochemical localization of an axonally transported plant lectin, Phaseolus vulgaris leucoagglutinin (PHA-L).Brain Res.290219238. 10.1016/0006-8993(84)90940-5

  • 98

    GerguesM. M.HanK. J.ChoiH. S.BrownB.ClausingK. J.TurnerV. S.et al (2020). Circuit and molecular architecture of a ventral hippocampal network.Nat. Neurosci.2314441452. 10.1038/s41593-020-0705-8

  • 99

    GhoshK. K.BurnsL. D.CockerE. D.NimmerjahnA.ZivY.GamalA. E.et al (2011). Miniaturized integration of a fluorescence microscope.Nat. Methods8871878. 10.1038/nmeth.1694

  • 100

    GimlichR. L.BraunJ. (1985). Improved fluorescent compounds for tracing cell lineage.Dev. Biol.109509514. 10.1016/0012-1606(85)90476-2

  • 101

    GokceO.StanleyG. M.TreutleinB.NeffN. F.CampJ. G.MalenkaR. C.et al (2016). Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq.Cell Rep.1611261137. 10.1016/j.celrep.2016.06.059

  • 102

    GolgiC. (1886). Sulla Fina Anatomia Degli Organi Centrali del Sistema Nervoso.Italy: Hoepli, 1886.

  • 103

    GomezJ. L.BonaventuraJ.LesniakW.MathewsW. B.Sysa-ShahP.RodriguezL. A.et al (2017). Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.Science357503507. 10.1126/science.aan2475

  • 104

    GongS.DoughtyM.HarbaughC. R.CumminsA.HattenM. E.HeintzN.et al (2007). Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs.J. Neurosci.2798179823. 10.1523/JNEUROSCI.2707-07.2007

  • 105

    GongY. (2015). The evolving capabilities of rhodopsin-based genetically encoded voltage indicators.Curr. Opin. Chem. Biol.278489. 10.1016/j.cbpa.2015.05.006

  • 106

    GongY.HuangC.LiJ. Z.GreweB. F.ZhangY.EismannS.et al (2015). High-speed recording of neural spikes in awake mice and flies with a fluorescent voltage sensor.Science35013611366. 10.1126/science.aab0810

  • 107

    GongY.WagnerM. J.Zhong, LiJ.SchnitzerM. J. (2014). Imaging neural spiking in brain tissue using FRET-opsin protein voltage sensors.Nat. Commun.5:3674. 10.1038/ncomms4674

  • 108

    GouwensN. W.SorensenS. A.BaftizadehF.BudzilloA.LeeB. R.JarskyT.et al (2020). Integrated Morphoelectric and Transcriptomic Classification of Cortical GABAergic Cells.Cell183935.e953.e. 10.1016/j.cell.2020.09.057

  • 109

    GovorunovaE. G.SineshchekovO. A.JanzR.LiuX.SpudichJ. L. (2015). Natural light-gated anion channels: A family of microbial rhodopsins for advanced optogenetics.Science349647650. 10.1126/science.aaa7484

  • 110

    GovorunovaE. G.SineshchekovO. A.RodarteE. M.JanzR.MorelleO.MelkonianM.et al (2017). The expanding family of natural anion channelrhodopsins reveals large variations in kinetics, conductance, and spectral sensitivity.Sci. Rep.7:43358. 10.1038/srep43358

  • 111

    GradinaruV.ZhangF.RamakrishnanC.MattisJ.PrakashR.DiesterI.et al (2010). Molecular and cellular approaches for diversifying and extending optogenetics.Cell141154165. 10.1016/j.cell.2010.02.037

  • 112

    GrayE. G. (1959). Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study.J. Anat.93420433.

  • 113

    GrayP. A.FuH.LuoP.ZhaoQ.YuJ.FerrariA.et al (2004). Mouse brain organization revealed through direct genome-scale TF expression analysis.Science30622552257. 10.1126/science.1104935

  • 114

    GreenbergM. E.ZiffE. B. (1984). Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.Nature311433438. 10.1038/311433a0

  • 115

    GrenierV.DawsB. R.LiuP.MillerE. W. (2019). Spying on Neuronal Membrane Potential with Genetically Targetable Voltage Indicators.J. Am. Chem. Soc.14113491358. 10.1021/jacs.8b11997

  • 116

    GreweB. F.LangerD.KasperH.KampaB. M.HelmchenF. (2010). High-speed in vivo calcium imaging reveals neuronal network activity with near-millisecond precision.Nat. Methods7399405. 10.1038/nmeth.1453

  • 117

    GriesbeckO.BairdG. S.CampbellR. E.ZachariasD. A.TsienR. Y. (2001). Reducing the environmental sensitivity of yellow fluorescent protein. Mechanism and applications.J. Biol. Chem.2762918829194. 10.1074/jbc.M102815200

  • 118

    GrimmJ. B.EnglishB. P.ChenJ.SlaughterJ. P.ZhangZ.RevyakinA.et al (2015). A general method to improve fluorophores for live-cell and single-molecule microscopy.Nat. Methods12244250. 3 p following 250. 10.1038/nmeth.3256

  • 119

    GuenthnerC. J.MiyamichiK.YangH. H.HellerH. C.LuoL. (2013). Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations.Neuron78773784. 10.1016/j.neuron.2013.03.025

  • 120

    GuettierJ.-M.GautamD.ScarselliM.Ruiz, de AzuaI.LiJ. H.et al (2009). A chemical-genetic approach to study G protein regulation of beta cell function in vivo.Proc. Natl. Acad. Sci. U.S.A.1061919719202. 10.1073/pnas.0906593106

  • 121

    HaggertyD. L.GreccoG. G.ReevesK. C.AtwoodB. (2020). Adeno-Associated Viral Vectors in Neuroscience Research.Mol. Ther. Methods Clin. Dev.176982. 10.1016/j.omtm.2019.11.012

  • 122

    HamaH.HiokiH.NamikiK.HoshidaT.KurokawaH.IshidateF.et al (2015). ScaleS: an optical clearing palette for biological imaging.Nat. Neurosci.1815181529. 10.1038/nn.4107

  • 123

    HamaH.KurokawaH.KawanoH.AndoR.ShimogoriT.NodaH.et al (2011). Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain.Nat. Neurosci.1414811488. 10.1038/nn.2928

  • 124

    HanW.TellezL. A.RangelM. J.MottaS. C.ZhangX.PerezI. O.et al (2017). Integrated control of predatory hunting by the central nucleus of the amygdala.Cell168311324.e18. 10.1016/j.cell.2016.12.027

  • 125

    HanX.BoydenE. S. (2007). Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution.PLoS One2:e299. 10.1371/journal.pone.0000299

  • 126

    HanY.KebschullJ. M.CampbellR. A. A.CowanD.ImhofF.ZadorA. M.et al (2018). The logic of single-cell projections from visual cortex.Nature5565156. 10.1038/nature26159

  • 127

    HanchateN. K.LeeE. J.EllisA.KondohK.KuangD.BasomR.et al (2020). Connect-seq to superimpose molecular on anatomical neural circuit maps.Proc. Natl. Acad. Sci. U.S.A.11743754384. 10.1073/pnas.1912176117

  • 128

    HangyaB.RanadeS. P.LorencM.KepecsA. (2015). Central cholinergic neurons are rapidly recruited by reinforcement feedback.Cell16211551168. 10.1016/j.cell.2015.07.057

  • 129

    HashikawaY.HashikawaK.RossiM. A.BasiriM. L.LiuY.JohnstonN. L.et al (2020). Transcriptional and spatial resolution of cell types in the mammalian habenula.Neuron106743.e758.e. 10.1016/j.neuron.2020.03.011

  • 130

    HelassaN.DürstC. D.CoatesC.KerruthS.ArifU.SchulzeC.et al (2018). Ultrafast glutamate sensors resolve high-frequency release at Schaffer collateral synapses.Proc. Natl. Acad. Sci. U.S.A.11555945599. 10.1073/pnas.1720648115

  • 131

    HelassaN.ZhangX.ConteI.ScaringiJ.EspositoE.BradleyJ.et al (2015). Fast-Response Calmodulin-Based Fluorescent Indicators Reveal Rapid Intracellular Calcium Dynamics.Sci. Rep.5:15978. 10.1038/srep15978

  • 132

    HelmchenF.FeeM. S.TankD. W.DenkW. (2001). A miniature head-mounted two-photon microscope. high-resolution brain imaging in freely moving animals.Neuron31903912. 10.1016/s0896-6273(01)00421-4

  • 133

    HendelT.MankM.SchnellB.GriesbeckO.BorstA.ReiffD. F. (2008). Fluorescence changes of genetic calcium indicators and OGB-1 correlated with neural activity and calcium in vivo and in vitro.J. Neurosci.2873997411. 10.1523/JNEUROSCI.1038-08.2008

  • 134

    HermanA. M.Ortiz-GuzmanJ.KochukovM.HermanI.QuastK. B.PatelJ. M.et al (2016). A cholinergic basal forebrain feeding circuit modulates appetite suppression.Nature538253256. 10.1038/nature19789

  • 135

    HillC. L.StephensG. J. (2021). An introduction to patch clamp recording.Methods Mol. Biol.2188119. 10.1007/978-1-0716-0818-0_1

  • 136

    HilleB. (2001). Ion Channels of Excitable Membranes.Sunderland, MA: Sinauer.

  • 137

    HochbaumD. R.ZhaoY.FarhiS. L.KlapoetkeN.WerleyC. A.KapoorV.et al (2014). All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins.Nat. Methods11825833. 10.1038/nmeth.3000

  • 138

    HooglandT. M.KuhnB.GöbelW.HuangW.NakaiJ.HelmchenF.et al (2009). Radially expanding transglial calcium waves in the intact cerebellum.Proc. Natl. Acad. Sci. U.S.A.10634963501. 10.1073/pnas.0809269106

  • 139

    HuangH.LeeS. H.YeC.LimaI. S.OhB.-C.LowellB. B.et al (2013). ROCK1 in AgRP neurons regulates energy expenditure and locomotor activity in male mice.Endocrinology15436603670. 10.1210/en.2013-1343

  • 140

    HuangL.KebschullJ. M.FürthD.MusallS.KaufmanM. T.ChurchlandA. K.et al (2020). BRICseq Bridges Brain-wide Interregional Connectivity to Neural Activity and Gene Expression in Single Animals.Cell182177.e188.e. 10.1016/j.cell.2020.05.029

  • 141

    InagakiS.AgetsumaM.OharaS.IijimaT.YokotaH.WazawaT.et al (2019). Imaging local brain activity of multiple freely moving mice sharing the same environment.Sci. Rep.9:7460. 10.1038/s41598-019-43897-x

  • 142

    InagakiS.TsutsuiH.SuzukiK.AgetsumaM.AraiY.JinnoY.et al (2017). Genetically encoded bioluminescent voltage indicator for multi-purpose use in wide range of bioimaging.Sci. Rep.7:42398. 10.1038/srep42398

  • 143

    InoD.HibinoH.NishiyamaM. (2021). A fluorescent sensor for the real-time measurement of extracellular oxytocin dynamics in the brain.BioRxiv [preprint] 10.1101/2021.07.30.454450

  • 144

    InoueM.TakeuchiA.HoriganeS.OhkuraM.Gengyo-AndoK.FujiiH.et al (2015). Rational design of a high-affinity, fast, red calcium indicator R-CaMP2.Nat. Methods126470. 10.1038/nmeth.3185

  • 145

    InoueM.TakeuchiA.ManitaS.HoriganeS.-I.SakamotoM.KawakamiR.et al (2019). Rational engineering of xcamps, a multicolor GECI suite for in vivo imaging of complex brain circuit dynamics.Cell1771346.e1360.e. 10.1016/j.cell.2019.04.007

  • 146

    IsobeT.TomitaM.MatsumotoJ.ItohT.FujitaT. (1983). Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.Nippon Ketsueki Gakkai Zasshi4615.

  • 147

    JendrykaM.PalchaudhuriM.UrsuD.van der VeenB.LissB.KätzelD.et al (2019). Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.Sci. Rep.9:4522. 10.1038/s41598-019-41088-2

  • 148

    JinL.BakerB.MealerR.CohenL.PieriboneV.PralleA.et al (2011). Random insertion of split-cans of the fluorescent protein venus into Shaker channels yields voltage sensitive probes with improved membrane localization in mammalian cells.J. Neurosci. Methods19919. 10.1016/j.jneumeth.2011.03.028

  • 149

    JingM.LiY.ZengJ.HuangP.SkirzewskiM.KljakicO.et al (2020). An optimized acetylcholine sensor for monitoring in vivo cholinergic activity.Nat. Methods1711391146. 10.1038/s41592-020-0953-2

  • 150

    JingM.ZhangP.WangG.FengJ.MesikL.ZengJ.et al (2018). A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies.Nat. Biotechnol.36726737. 10.1038/nbt.4184

  • 151

    JohnsD. C.MarxR.MainsR. E.O’RourkeB.MarbánE. (1999). Inducible genetic suppression of neuronal excitability.J. Neurosci.1916911697. 10.1523/JNEUROSCI.19-05-01691.1999

  • 152

    JunJ. J.SteinmetzN. A.SiegleJ. H.DenmanD. J.BauzaM.BarbaritsB.et al (2017). Fully integrated silicon probes for high-density recording of neural activity.Nature551232236. 10.1038/nature24636

  • 153

    Kakava-GeorgiadouN.ZwartkruisM. M.Bullich-VilarrubiasC.LuijendijkM. C. M.GarnerK. M.van der PlasseG.et al (2019). An Intersectional Approach to Target Neural Circuits With Cell- and Projection-Type Specificity: Validation in the Mesolimbic Dopamine System.Front. Mol. Neurosci.12:49. 10.3389/fnmol.2019.00049

  • 154

    KannanM.VasanG.HuangC.HazizaS.LiJ. Z.InanH.et al (2018). Fast, in vivo voltage imaging using a red fluorescent indicator.Nat. Methods1511081116. 10.1038/s41592-018-0188-7

  • 155

    KannanM.VasanG.PieriboneV. A. (2019). Optimizing strategies for developing genetically encoded voltage indicators.Front. Cell. Neurosci.13:53. 10.3389/fncel.2019.00053

  • 156

    KatoH. E.KamiyaM.SugoS.ItoJ.TaniguchiR.OritoA.et al (2015). Atomistic design of microbial opsin-based blue-shifted optogenetics tools.Nat. Commun.6:7177. 10.1038/ncomms8177

  • 157

    KatzL. C.BurkhalterA.DreyerW. J. (1984). Fluorescent latex microspheres as a retrograde neuronal marker for in vivo and in vitro studies of visual cortex.Nature310498500. 10.1038/310498a0

  • 158

    KatzL. C.LaroviciD. M. (1990). Green fluorescent latex microspheres: a new retrograde tracer.Neuroscience34511520. 10.1016/0306-4522(90)90159-2

  • 159

    KeM.-T.NakaiY.FujimotoS.TakayamaR.YoshidaS.KitajimaT. S.et al (2016). Super-Resolution Mapping of Neuronal Circuitry With an Index-Optimized Clearing Agent.Cell Rep.1427182732. 10.1016/j.celrep.2016.02.057

  • 160

    KebschullJ. M.Garcia, da SilvaP.ReidA. P.PeikonI. D.AlbeanuD. F.et al (2016). High-Throughput Mapping of Single-Neuron Projections by Sequencing of Barcoded RNA.Neuron91975987. 10.1016/j.neuron.2016.07.036

  • 161

    KimC. K.AdhikariA.DeisserothK. (2017). Integration of optogenetics with complementary methodologies in systems neuroscience.Nat. Rev. Neurosci.18222235. 10.1038/nrn.2017.15

  • 162

    KimJ.ZhangX.MuralidharS.LeBlancS. A.TonegawaS. (2017). Basolateral to central amygdala neural circuits for appetitive behaviors.Neuron931464.e1479.e. 10.1016/j.neuron.2017.02.034

  • 163

    KimC. K.SanchezM. I.HoerbeltP.FennoL. E.MalenkaR. C.DeisserothK.et al (2020). A molecular calcium integrator reveals a striatal cell type driving aversion.Cell1832003.e2019.e. 10.1016/j.cell.2020.11.015

  • 164

    KimJ.ZhaoT.PetraliaR. S.YuY.PengH.MyersE.et al (2011). mGRASP enables mapping mammalian synaptic connectivity with light microscopy.Nat. Methods996102. 10.1038/nmeth.1784

  • 165

    KingB. M. (2006). The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight.Physiol. Behav.87221244. 10.1016/j.physbeh.2005.10.007

  • 166

    KlapoetkeN. C.MurataY.KimS. S.PulverS. R.Birdsey-BensonA.ChoY. K.et al (2014). Independent optical excitation of distinct neural populations.Nat. Methods11338346. 10.1038/nmeth.2836

  • 167

    KnöpfelT.SongC. (2019). Optical voltage imaging in neurons: moving from technology development to practical tool.Nat. Rev. Neurosci.20719727. 10.1038/s41583-019-0231-4

  • 168

    KöbbertC.AppsR.BechmannI.LanciegoJ. L.MeyJ.ThanosS. (2000). Current concepts in neuroanatomical tracing.Prog. Neurobiol.62327351. 10.1016/S0301-0082(00)00019-8

  • 169

    KostyukA. I.DemidovichA. D.KotovaD. A.BelousovV. V.BilanD. S. (2019). Circularly Permuted Fluorescent Protein-Based Indicators: History, Principles, and Classification.Int. J. Mol. Sci20:4200. 10.3390/ijms20174200

  • 170

    KraljJ. M.DouglassA. D.HochbaumD. R.MaclaurinD.CohenA. E. (2011). Optical recording of action potentials in mammalian neurons using a microbial rhodopsin.Nat. Methods99095. 10.1038/nmeth.1782

  • 171

    KristenssonK. (1977). Retrograde Axonal Transport of Horseradish Peroxidase.Acta Neuropathol.38143147.

  • 172

    KristenssonK.OlssonY. (1971). Uptake and Retrograde Axonal Transport of Peroxidase in Hypoglossal Neurones.Acta Neuropathol1919.

  • 173

    KuhlmanS. J.HuangZ. J. (2008). High-resolution labeling and functional manipulation of specific neuron types in mouse brain by Cre-activated viral gene expression.PLoS One3:e2005. 10.1371/journal.pone.0002005

  • 174

    KuypersH. G.UgoliniG. (1990). Viruses as transneuronal tracers.Trends Neurosci.137175. 10.1016/0166-2236(90)90071-h

  • 175

    LamA. J.St-PierreF.GongY.MarshallJ. D.CranfillP. J.BairdM. A.et al (2012). Improving FRET dynamic range with bright green and red fluorescent proteins.Nat. Methods910051012. 10.1038/nmeth.2171

  • 176

    LanciegoJ. L.WouterloodF. G. (2011). A half century of experimental neuroanatomical tracing.J. Chem. Neuroanat.42157183. 10.1016/j.jchemneu.2011.07.001

  • 177

    LavoieA.LiuB.-H. (2020). Canine adenovirus 2: A natural choice for brain circuit dissection.Front. Mol. Neurosci.13:9. 10.3389/fnmol.2020.00009

  • 178

    LavondD. G.SteinmetzJ. E. (2003). “Lesion techniques for behavioral experiments,” in Handbook of Classical Conditioning.MurphyE. S.McSweeneyF. K. (Boston, MA: Springer US), 249276. 10.1007/978-1-4615-0263-0_8

  • 179

    LiL.TasicB.MichevaK. D.IvanovV. M.SpletterM. L.SmithS. J.et al (2010). Visualizing the distribution of synapses from individual neurons in the mouse brain.PLoS One5:e11503. 10.1371/journal.pone.0011503

  • 180

    LilleyC. E.GroutsiF.HanZ.PalmerJ. A.AndersonP. N.LatchmanD. S.et al (2001). Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.J. Virol.7543434356. 10.1128/JVI.75.9.4343-4356.2001

  • 181

    LimaS. Q.HromádkaT.ZnamenskiyP.ZadorA. M. (2009). PINP: a new method of tagging neuronal populations for identification during in vivo electrophysiological recording.PLoS One4:e6099. 10.1371/journal.pone.0006099

  • 182

    LinC.-W.SimS.AinsworthA.OkadaM.KelschW.LoisC. (2010). Genetically increased cell-intrinsic excitability enhances neuronal integration into adult brain circuits.Neuron653239. 10.1016/j.neuron.2009.12.001

  • 183

    LinJ. Y. (2011). A user’s guide to channelrhodopsin variants: features, limitations and future developments.Exp. Physiol.961925. 10.1113/expphysiol.2009.051961

  • 184

    LinJ. Y.KnutsenP. M.MullerA.KleinfeldD.TsienR. Y. (2013). ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.Nat. Neurosci.1614991508. 10.1038/nn.3502

  • 185

    LinJ. Y.LinM. Z.SteinbachP.TsienR. Y. (2009). Characterization of engineered channelrhodopsin variants with improved properties and kinetics.Biophys. J.9618031814. 10.1016/j.bpj.2008.11.034

  • 186

    LipovsekM.BardyC.CadwellC. R.HadleyK.KobakD.TripathyS. J. (2021). Patch-seq: Past. Present, and Future.J. Neurosci.41937946. 10.1523/JNEUROSCI.1653-20.2020

  • 187

    LoL.AndersonD. J. (2011). A Cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons.Neuron72938950. 10.1016/j.neuron.2011.12.002

  • 188

    LobasM. A.TaoR.NagaiJ.KronschlägerM. T.BordenP. M.MarvinJ. S.et al (2019). A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP.Nat. Commun.10:711. 10.1038/s41467-019-08441-5

  • 189

    LohseM.BajoV. M.KingA. J.WillmoreB. D. B. (2020). Neural circuits underlying auditory contrast gain control and their perceptual implications.Nat. Commun.11:324. 10.1038/s41467-019-14163-5

  • 190

    LundbyA.MutohH.DimitrovD.AkemannW.KnöpfelT. (2008). Engineering of a genetically encodable fluorescent voltage sensor exploiting fast Ci-VSP voltage-sensing movements.PLoS One3:e2514. 10.1371/journal.pone.0002514

  • 191

    LuquetS.PerezF. A.HnaskoT. S.PalmiterR. D. (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.Science310683685. 10.1126/science.1115524

  • 192

    LutasA.FernandoK.ZhangS. X.SambangiA.AndermannM. L. (2022). History-dependent dopamine release increases cAMP levels in most basal amygdala glutamatergic neurons to control learning.Cell Rep.38:110297. 10.1016/j.celrep.2022.110297

  • 193

    LütckeH.MurayamaM.HahnT.MargolisD. J.AstoriS.Zum Altenet al (2010). Optical recording of neuronal activity with a genetically-encoded calcium indicator in anesthetized and freely moving mice.Front. Neural Circuits4:9. 10.3389/fncir.2010.00009

  • 194

    LyfordG. L.YamagataK.KaufmannW. E.BarnesC. A.SandersL. K.CopelandN. G.et al (1995). Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.Neuron14433445. 10.1016/0896-6273(95)90299-6

  • 195

    MaddenC. J.MorrisonS. F. (2019). Central nervous system circuits that control body temperature.Neurosci. Lett.696225232. 10.1016/j.neulet.2018.11.027

  • 196

    MagnusC. J.LeeP. H.BonaventuraJ.ZemlaR.GomezJ. L.RamirezM. H.et al (2019). Ultrapotent chemogenetics for research and potential clinical applications.Science364:eaav5282. 10.1126/science.aav5282

  • 197

    ManvichD. F.WebsterK. A.FosterS. L.FarrellM. S.RitchieJ. C.PorterJ. H.et al (2018). The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice.Sci. Rep.8:3840. 10.1038/s41598-018-22116-z

  • 198

    MartinX.DolivoM. (1983). Neuronal and transneuronal tracing in the trigeminal system of the rat using the herpes virus suis.Brain Res.273253276. 10.1016/0006-8993(83)90850-8

  • 199

    MarvinJ. S.BorghuisB. G.TianL.CichonJ.HarnettM. T.AkerboomJ.et al (2013). An optimized fluorescent probe for visualizing glutamate neurotransmission.Nat. Methods10162170. 10.1038/nmeth.2333

  • 200

    MarvinJ. S.SchollB.WilsonD. E.PodgorskiK.KazemipourA.MüllerJ. A.et al (2018). Stability, affinity, and chromatic variants of the glutamate sensor iGluSnFR.Nat. Methods15936939. 10.1038/s41592-018-0171-3

  • 201

    MarvinJ. S.ShimodaY.MagloireV.LeiteM.KawashimaT.JensenT. P.et al (2019). A genetically encoded fluorescent sensor for in vivo imaging of GABA.Nat. Methods16763770. 10.1038/s41592-019-0471-2

  • 202

    MassengillC. I.Day-CooneyJ.MaoT.ZhongH. (2021). Genetically encoded sensors towards imaging cAMP and PKA activity in vivo.J. Neurosci. Methods362:109298. 10.1016/j.jneumeth.2021.109298

  • 203

    MatsuiS.SasakiT.KohnoD.YakuK.InutsukaA.Yokota-HashimotoH.et al (2018). Neuronal SIRT1 regulates macronutrient-based diet selection through FGF21 and oxytocin signalling in mice.Nat. Commun.9:4604. 10.1038/s41467-018-07033-z

  • 204

    MatsumotoK.MitaniT. T.HoriguchiS. A.KaneshiroJ.MurakamiT. C.ManoT.et al (2019). Advanced CUBIC tissue clearing for whole-organ cell profiling.Nat. Protoc.1435063537. 10.1038/s41596-019-0240-9

  • 205

    MattisJ.TyeK. M.FerencziE. A.RamakrishnanC.O’SheaD. J.PrakashR.et al (2011). Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins.Nat. Methods9159172. 10.1038/nmeth.1808

  • 206

    McCullochW. S.PittsW. (1943). A logical calculus of the ideas immanent in nervous activity.Bull. Math. Biophys.5115133. 10.1007/BF02478259

  • 207

    MeinkeG.BohmA.HauberJ.PisabarroM. T.BuchholzF. (2016). Cre recombinase and other tyrosine recombinases.Chem. Rev.1161278512820. 10.1021/acs.chemrev.6b00077

  • 208

    MishinaY.MutohH.SongC.KnöpfelT. (2014). Exploration of genetically encoded voltage indicators based on a chimeric voltage sensing domain.Front. Mol. Neurosci.7:78. 10.3389/fnmol.2014.00078

  • 209

    MiyawakiA.LlopisJ.HeimR.McCafferyJ. M.AdamsJ. A.IkuraM.et al (1997). Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin.Nature388882887. 10.1038/42264

  • 210

    Mollinedo-GajateI.SongC.KnöpfelT. (2021). Genetically encoded voltage indicators.Adv. Exp. Med. Biol.1293209224. 10.1007/978-981-15-8763-4_12

  • 211

    Muñoz-ManchadoA. B.Bengtsson GonzalesC.ZeiselA.MungubaH.BekkoucheB.SkeneN. G.et al (2018). Diversity of Interneurons in the Dorsal Striatum Revealed by Single-Cell RNA Sequencing and PatchSeq.Cell Rep.242179.e2190.e. 10.1016/j.celrep.2018.07.053

  • 212

    MurakamiT. C.ManoT.SaikawaS.HoriguchiS. A.ShigetaD.BabaK.et al (2018). A three-dimensional single-cell-resolution whole-brain atlas using CUBIC-X expansion microscopy and tissue clearing.Nat. Neurosci.21625637. 10.1038/s41593-018-0109-1

  • 213

    MutohH.PerronA.DimitrovD.IwamotoY.AkemannW.ChudakovD. M.et al (2009). Spectrally-resolved response properties of the three most advanced FRET based fluorescent protein voltage probes.PLoS One4:e4555. 10.1371/journal.pone.0004555

  • 214

    NagaiY.MiyakawaN.TakuwaH.HoriY.OyamaK.JiB.et al (2020). Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.Nat. Neurosci.2311571167. 10.1038/s41593-020-0661-3

  • 215

    NagelG.SzellasT.HuhnW.KateriyaS.AdeishviliN.BertholdP.et al (2003). Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.Proc. Natl. Acad. Sci. U.S.A.1001394013945. 10.1073/pnas.1936192100

  • 216

    NakaiJ.OhkuraM.ImotoK. (2001). A high signal-to-noise Ca(2+) probe composed of a single green fluorescent protein.Nat. Biotechnol.19137141. 10.1038/84397

  • 217

    NakajimaK.WessJ. (2012). Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor.Mol. Pharmacol.82575582. 10.1124/mol.112.080358

  • 218

    NarahashiT.MooreJ. W.ScottW. R. (1964). Tetrodotoxin blockage of sodium conductance increase in lobster giant axons.J. Gen. Physiol.47965974. 10.1085/jgp.47.5.965

  • 219

    NectowA. R.NestlerE. J. (2020). Viral tools for neuroscience.Nat. Rev. Neurosci.21669681. 10.1038/s41583-020-00382-z

  • 220

    NederpeltI.BunnikJ.IJzermanA. P.HeitmanL. H. (2016). Kinetic Profile of Neuropeptide-Receptor Interactions.Trends Neurosci.39830839. 10.1016/j.tins.2016.09.008

  • 221

    NeherE.SakmannB. (1976). Noise analysis of drug induced voltage clamp currents in denervated frog muscle fibres.J. Physiol.258705729. 10.1113/jphysiol.1976.sp011442

  • 222

    NewmasterK. T.KronmanF. A.WuY.-T.KimY. (2021). Seeing the forest and its trees together: implementing 3D light microscopy pipelines for cell type mapping in the mouse brain.Front. Neuroanat.15:787601. 10.3389/fnana.2021.787601

  • 223

    OeY.WangX.PatriarchiT.KonnoA.OzawaK.YahagiK.et al (2020). Author Correction: Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance.Nat. Commun.11:3447. 10.1038/s41467-020-17059-x

  • 224

    OhJ.LeeC.KaangB.-K. (2019). Imaging and analysis of genetically encoded calcium indicators linking neural circuits and behaviors.Korean J. Physiol. Pharmacol.23237249. 10.4196/kjpp.2019.23.4.237

  • 225

    OhkuraM.MatsuzakiM.KasaiH.ImotoK.NakaiJ. (2005). Genetically encoded bright Ca2+ probe applicable for dynamic Ca2+ imaging of dendritic spines.Anal. Chem.7758615869. 10.1021/ac0506837

  • 226

    OhkuraM.SasakiT.KobayashiC.IkegayaY.NakaiJ. (2012a). An improved genetically encoded red fluorescent Ca2+ indicator for detecting optically evoked action potentials.PLoS One7:e39933. 10.1371/journal.pone.0039933

  • 227

    OhkuraM.SasakiT.SadakariJ.Gengyo-AndoK.Kagawa-NagamuraY.KobayashiC.et al (2012b). Genetically encoded green fluorescent Ca2+ indicators with improved detectability for neuronal Ca2+ signals.PLoS One7:e51286. 10.1371/journal.pone.0051286

  • 228

    PatelJ. M.SwansonJ.UngK.HermanA.HansonE.Ortiz-GuzmanJ.et al (2019). Sensory perception drives food avoidance through excitatory basal forebrain circuits.eLife8:e44548. 10.7554/eLife.44548

  • 229

    PatriarchiT.ChoJ. R.MertenK.HoweM. W.MarleyA.XiongW.-H.et al (2018). Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors.Science360:eaat4422. 10.1126/science.aat4422

  • 230

    PatriarchiT.MohebiA.SunJ.MarleyA.LiangR.DongC.et al (2020). An expanded palette of dopamine sensors for multiplex imaging in vivo.Nat. Methods1711471155. 10.1038/s41592-020-0936-3

  • 231

    Pérez KoldenkovaV.NagaiT. (2013). Genetically encoded Ca(2+) indicators: properties and evaluation.Biochim. Biophys. Acta183317871797. 10.1016/j.bbamcr.2013.01.011

  • 232

    PerronA.MutohH.AkemannW.GautamS. G.DimitrovD.IwamotoY.et al (2009). Second and third generation voltage-sensitive fluorescent proteins for monitoring membrane potential.Front. Mol. Neurosci.2:5. 10.3389/neuro.02.005.2009

  • 233

    PetreanuL.HuberD.SobczykA.SvobodaK. (2007). Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections.Nat. Neurosci.10663668. 10.1038/nn1891

  • 234

    PetreanuL.MaoT.SternsonS. M.SvobodaK. (2009). The subcellular organization of neocortical excitatory connections.Nature45711421145. 10.1038/nature07709

  • 235

    PiaoH. H.RajakumarD.KangB. E.KimE. H.BakerB. J. (2015). Combinatorial mutagenesis of the voltage-sensing domain enables the optical resolution of action potentials firing at 60 Hz by a genetically encoded fluorescent sensor of membrane potential.J. Neurosci.35372385. 10.1523/JNEUROSCI.3008-14.2015

  • 236

    PiatkevichK. D.BensussenS.TsengH.-A.ShroffS. N.Lopez-HuertaV. G.ParkD.et al (2019). Population imaging of neural activity in awake behaving mice.Nature574413417. 10.1038/s41586-019-1641-1

  • 237

    PiatkevichK. D.JungE. E.StraubC.LinghuC.ParkD.SukH.-J.et al (2018). A robotic multidimensional directed evolution approach applied to fluorescent voltage reporters.Nat. Chem. Biol.14352360. 10.1038/s41589-018-0004-9

  • 238

    PiccolinoM. (1997). Luigi Galvani and animal electricity: two centuries after the foundation of electrophysiology.Trends Neurosci.20443448. 10.1016/s0166-2236(97)01101-6

  • 239

    PiccolinoM. (1998). Animal electricity and the birth of electrophysiology: the legacy of Luigi Galvani.Brain Res. Bull.46381407. 10.1016/S0361-9230(98)00026-4

  • 240

    PorumbT.YauP.HarveyT. S.IkuraM. (1994). A calmodulin-target peptide hybrid molecule with unique calcium-binding properties.Protein Eng.7109115. 10.1093/protein/7.1.109

  • 241

    QianT.WangH.WangP.GengL.MeiL.OsakadaT.et al (2022). Compartmental neuropeptide release measured using a new oxytocin sensor.BioRxiv [preprint] 10.1101/2022.02.10.480016

  • 242

    QianY.CosioD. M. O.PiatkevichK. D.AufmkolkS.SuW.-C.CelikerO. T.et al (2020). Improved genetically encoded near-infrared fluorescent calcium ion indicators for in vivo imaging.PLoS Biol.18:e3000965. 10.1371/journal.pbio.3000965

  • 243

    QuirinS.JacksonJ.PeterkaD. S.YusteR. (2014). Simultaneous imaging of neural activity in three dimensions.Front. Neural Circuits8:29. 10.3389/fncir.2014.00029

  • 244

    RaoS.ChenR.LaRoccaA. A.ChristiansenM. G.SenkoA. W.ShiC. H.et al (2019). Remotely controlled chemomagnetic modulation of targeted neural circuits.Nat. Nanotechnol.14967973. 10.1038/s41565-019-0521-z

  • 245

    RedolfiN.García-CasasP.FornettoC.SondaS.PizzoP.PendinD. (2021). Lighting up ca2+ dynamics in animal models.Cells10:2133. 10.3390/cells10082133

  • 246

    ReiffD. F.IhringA.GuerreroG.IsacoffE. Y.JoeschM.NakaiJ.et al (2005). In vivo performance of genetically encoded indicators of neural activity in flies.J. Neurosci.2547664778. 10.1523/JNEUROSCI.4900-04.2005

  • 247

    ReijmersL. G.PerkinsB. L.MatsuoN.MayfordM. (2007). Localization of a stable neural correlate of associative memory.Science31712301233. 10.1126/science.1143839

  • 248

    RenD.NavarroB.XuH.YueL.ShiQ.ClaphamD. E. (2001). A prokaryotic voltage-gated sodium channel.Science29423722375. 10.1126/science.1065635

  • 249

    ReynoldsS. M.BerridgeK. C. (2002). Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste “liking”/”disliking” reactions, place preference/avoidance, and fear.J. Neurosci.2273087320. doi:20026734.10.1523/JNEUROSCI.22-16-07308.2002

  • 250

    RootD. H.Mejias-AponteC. A.QiJ.MoralesM. (2014). Role of glutamatergic projections from ventral tegmental area to lateral habenula in aversive conditioning.J. Neurosci.341390613910. 10.1523/JNEUROSCI.2029-14.2014

  • 251

    RoseT.GoltsteinP. M.PortuguesR.GriesbeckO. (2014). Putting a finishing touch on GECIs.Front. Mol. Neurosci.7:88. 10.3389/fnmol.2014.00088

  • 252

    RossiM. A.BasiriM. L.LiuY.HashikawaY.HashikawaK.FennoL. E.et al (2021). Transcriptional and functional divergence in lateral hypothalamic glutamate neurons projecting to the lateral habenula and ventral tegmental area.Neuron1093823.e3837.e. 10.1016/j.neuron.2021.09.020

  • 253

    RossiM. A.BasiriM. L.McHenryJ. A.KosykO.OtisJ. M.van den MunkhofH. E.et al (2019). Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding.Science36412711274. 10.1126/science.aax1184

  • 254

    RubaiyH. N. (2017). A short guide to electrophysiology and ion channels.J. Pharm. Pharm. Sci.204867. 10.18433/J32P6R

  • 255

    RuderL.SchinaR.KanodiaH.Valencia-GarciaS.PivettaC.ArberS. (2021). A functional map for diverse forelimb actions within brainstem circuitry.Nature590445450. 10.1038/s41586-020-03080-z

  • 256

    SabatiniB. L.TianL. (2020). Imaging Neurotransmitter and Neuromodulator Dynamics In Vivo with Genetically Encoded Indicators.Neuron1081732. 10.1016/j.neuron.2020.09.036

  • 257

    SaitoM.IwawakiT.TayaC.YonekawaH.NodaM.InuiY.et al (2001). Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice.Nat. Biotechnol.19746750. 10.1038/90795

  • 258

    SakaiR.Repunte-CanonigoV.RajC. D.KnöpfelT. (2001). Design and characterization of a DNA-encoded, voltage-sensitive fluorescent protein.Eur. J. Neurosci.1323142318. 10.1046/j.0953-816x.2001.01617.x

  • 259

    SakuraiK.ZhaoS.TakatohJ.RodriguezE.LuJ.LeavittA. D.et al (2016). Capturing and Manipulating Activated Neuronal Ensembles with CANE Delineates a Hypothalamic Social-Fear Circuit.Neuron92739753. 10.1016/j.neuron.2016.10.015

  • 260

    SaleebaC.DempseyB.LeS.GoodchildA.McMullanS. (2019). A student’s guide to neural circuit tracing.Front. Neurosci.13:897. 10.3389/fnins.2019.00897

  • 261

    SaundersA.MacoskoE. Z.WysokerA.GoldmanM.KrienenF. M.de RiveraH.et al (2018). Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain.Cell1741015.e1030.e. 10.1016/j.cell.2018.07.028

  • 262

    ScalaF.KobakD.BernabucciM.BernaertsY.CadwellC. R.CastroJ. R.et al (2021). Phenotypic variation of transcriptomic cell types in mouse motor cortex.Nature598144150. 10.1038/s41586-020-2907-3

  • 263

    SchwarzL. A.MiyamichiK.GaoX. J.BeierK. T.WeissbourdB.DeLoachK. E.et al (2015). Viral-genetic tracing of the input-output organization of a central noradrenaline circuit.Nature5248892. 10.1038/nature14600

  • 264

    ScovilleW. B.MilnerB. (1957). Loss of recent memory after bilateral hippocampal lesions.J. Neurol. Neurosurg. Psychiatr.201121. 10.1136/jnnp.20.1.11

  • 265

    ShapiroM. G.FrazierS. J.LesterH. A. (2012). Unparalleled control of neural activity using orthogonal pharmacogenetics.ACS Chem. Neurosci.3619629. 10.1021/cn300053q

  • 266

    SharpeM. J.BatchelorH. M.MuellerL. E.GardnerM. P. H.SchoenbaumG. (2021). Past experience shapes the neural circuits recruited for future learning.Nat. Neurosci.24391400. 10.1038/s41593-020-00791-4

  • 267

    ShimomuraO.JohnsonF. H.SaigaY. (1962). Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan.Aequorea. J. Cell. Comp. Physiol.59223239. 10.1002/jcp.1030590302

  • 268

    ShivangeA. V.BordenP. M.MuthusamyA. K.NicholsA. L.BeraK.BaoH.et al (2019). Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors.J. Gen. Physiol.151738757. 10.1085/jgp.201812201

  • 269

    ShobeJ. L.ClaarL. D.ParhamiS.BakhurinK. I.MasmanidisS. C. (2015). Brain activity mapping at multiple scales with silicon microprobes containing 1,024 electrodes.J. Neurophysiol.11420432052. 10.1152/jn.00464.2015

  • 270

    SiegelM. S.IsacoffE. Y. (1997). A genetically encoded optical probe of membrane voltage.Neuron19735741. 10.1016/s0896-6273(00)80955-1

  • 271

    SiemianJ. N.ArenivarM. A.SarsfieldS.BorjaC. B.RussellC. N.AponteY. (2021). Lateral hypothalamic LEPR neurons drive appetitive but not consummatory behaviors.Cell Rep.36109615. 10.1016/j.celrep.2021.109615

  • 272

    SikeÁWengenrothJ.UpīteJ.BrüningT.EirizI.SánthaP.et al (2017). Improved method for cannula fixation for long-term intracerebral brain infusion.J. Neurosci. Methods290145150. 10.1016/j.jneumeth.2017.07.026

  • 273

    SohnJ.-W. (2014). Network of Hypothalamic Neurons that Control Appetite.BMB Rep.48229233. 10.5483/BMBRep.2015.48.4.272

  • 274

    SongJ. H.LucaciD.CalangiuI.BrownM. T. C.ParkJ. S.KimJ.et al (2018). Combining mGRASP and Optogenetics Enables High-Resolution Functional Mapping of Descending Cortical Projections.Cell Rep.2410711080. 10.1016/j.celrep.2018.06.076

  • 275

    SoudaisC.Laplace-BuilheC.KissaK.KremerE. J. (2001). Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo.FASEB J.1522832285. 10.1096/fj.01-0321fje

  • 276

    SrinivasanP.GriffinN. M.JoshiP.ThakurD.Nguyen-LeA.McCotterS.et al (2019). An Autonomous Molecular Bioluminescent Reporter (AMBER) for voltage imaging in freely moving animals.BioRxiv [preprint] 10.1101/845198

  • 277

    SteinbergE. E.BoivinJ. R.SaundersB. T.WittenI. B.DeisserothK.JanakP. H. (2014). Positive reinforcement mediated by midbrain dopamine neurons requires D1 and D2 receptor activation in the nucleus accumbens.PLoS One9:e94771. 10.1371/journal.pone.0094771

  • 278

    StellarS. (1953). a history of neurological surgery. A. earl walker.Q. Rev. Biol.28162162. 10.1086/399528

  • 279

    SternsonS. M.AtasoyD. (2014). Agouti-related protein neuron circuits that regulate appetite.Neuroendocrinology10095102. 10.1159/000369072

  • 280

    StoeckelK.SchwabM.ThoenenH. (1977). Role of gangliosides in the uptake and retrograde axonal transport of cholera and tetanus toxin as compared to nerve growth factor and wheat germ agglutinin.Brain Res.132273285. 10.1016/0006-8993(77)90421-8

  • 281

    St-PierreF.MarshallJ. D.YangY.GongY.SchnitzerM. J.LinM. Z. (2014). High-fidelity optical reporting of neuronal electrical activity with an ultrafast fluorescent voltage sensor.Nat. Neurosci.17884889. 10.1038/nn.3709

  • 282

    SunF.ZengJ.JingM.ZhouJ.FengJ.OwenS. F.et al (2018). A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice.Cell174481.e496.e. 10.1016/j.cell.2018.06.042

  • 283

    SunY.-C.ChenX.FischerS.LuS.ZhanH.GillisJ.et al (2021). Integrating barcoded neuroanatomy with spatial transcriptional profiling enables identification of gene correlates of projections.Nat. Neurosci.24873885. 10.1038/s41593-021-00842-4

  • 284

    SundukovaM.PriftiE.BucciA.KirillovaK.SerraoJ.ReymondL.et al (2019). A chemogenetic approach for the optical monitoring of voltage in neurons.Angew. Chem. Int. Ed. Engl.5823412344. 10.1002/anie.201812967

  • 285

    SungU.Sepehri-RadM.PiaoH. H.JinL.HughesT.CohenL. B.et al (2015). Developing fast fluorescent protein voltage sensors by optimizing FRET interactions.PLoS One10:e0141585. 10.1371/journal.pone.0141585

  • 286

    SusakiE. A.TainakaK.PerrinD.KishinoF.TawaraT.WatanabeT. M.et al (2014). Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis.Cell157726739. 10.1016/j.cell.2014.03.042

  • 287

    SuzukiE.NakayamaM. (2011). VCre/VloxP and SCre/SloxP: new site-specific recombination systems for genome engineering.Nucleic Acids Res.39:e49. 10.1093/nar/gkq1280

  • 288

    SweeneyS. T.BroadieK.KeaneJ.NiemannH.O’KaneC. J. (1995). Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects.Neuron14341351. 10.1016/0896-6273(95)90290-2

  • 289

    TalliniY. N.OhkuraM.ChoiB.-R.JiG.ImotoK.DoranR.et al (2006). Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2.Proc. Natl. Acad. Sci. U.S.A.10347534758. 10.1073/pnas.0509378103

  • 290

    TepeB.HillM. C.PekarekB. T.HuntP. J.MartinT. J.MartinJ. F.et al (2018). Single-Cell RNA-Seq of Mouse Olfactory Bulb Reveals Cellular Heterogeneity and Activity-Dependent Molecular Census of Adult-Born Neurons.Cell Rep.252689.e2703.e. 10.1016/j.celrep.2018.11.034

  • 291

    TervoD. G. R.HwangB.-Y.ViswanathanS.GajT.LavzinM.RitolaK. D.et al (2016). A designer AAV variant permits efficient retrograde access to projection neurons.Neuron92372382. 10.1016/j.neuron.2016.09.021

  • 292

    TewsonP. H.MartinkaS.ShanerN. C.HughesT. E.QuinnA. M. (2016). New DAG and cAMP Sensors Optimized for Live-Cell Assays in Automated Laboratories.J. Biomol. Screen.21298305. 10.1177/1087057115618608

  • 293

    TianL.HiresS. A.MaoT.HuberD.ChiappeM. E.ChalasaniS. H.et al (2009). Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators.Nat. Methods6875881. 10.1038/nmeth.1398

  • 294

    TomerR.YeL.HsuehB.DeisserothK. (2014). Advanced CLARITY for rapid and high-resolution imaging of intact tissues.Nat. Protoc.916821697. 10.1038/nprot.2014.123

  • 295

    TyeK. M.PrakashR.KimS.-Y.FennoL. E.GrosenickL.ZarabiH.et al (2011). Amygdala circuitry mediating reversible and bidirectional control of anxiety.Nature471358362. 10.1038/nature09820

  • 296

    UgoliniG. (1995). Specificity of Rabies Virus as a Transneuronal Tracer.J. Comp. Neurol.356457480. 10.1002/cne.903560312

  • 297

    UgoliniG. (2010). Advances in viral transneuronal tracing.J. Neurosci. Methods194220. 10.1016/j.jneumeth.2009.12.001

  • 298

    UngerE. K.KellerJ. P.AltermattM.LiangR.MatsuiA.DongC.et al (2020). Directed evolution of a selective and sensitive serotonin sensor via machine learning.Cell1831986.e2002.e. 10.1016/j.cell.2020.11.040

  • 299

    VardyE.RobinsonJ. E.LiC.OlsenR. H. J.DiBertoJ. F.GiguereP. M.et al (2015). A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior.Neuron86936946. 10.1016/j.neuron.2015.03.065

  • 300

    VercelliA.RepiciM.GarbossaD.GrimaldiA. (2000). Recent techniques for tracing pathways in the central nervous system of developing and adult mammals.Brain Res. Bull.511128. 10.1016/S0361-9230(99)00229-4

  • 301

    VerderioC.CocoS.BacciA.RossettoO.De CamilliP.MontecuccoC.et al (1999). Tetanus toxin blocks the exocytosis of synaptic vesicles clustered at synapses but not of synaptic vesicles in isolated axons.J. Neurosci.1967236732. 10.1523/JNEUROSCI.19-16-06723.1999

  • 302

    VierockJ.Rodriguez-RozadaS.DieterA.PieperF.SimsR.TenediniF.et al (2021). BiPOLES is an optogenetic tool developed for bidirectional dual-color control of neurons.Nat. Commun.12:4527. 10.1038/s41467-021-24759-5

  • 303

    WallaceM. L.HuangK. W.HochbaumD.HyunM.RadeljicG.SabatiniB. L. (2020). Anatomical and single-cell transcriptional profiling of the murine habenular complex.eLife9:e51271. 10.7554/eLife.51271

  • 304

    WanJ.PengW.LiX.QianT.SongK.ZengJ.et al (2021). A genetically encoded sensor for measuring serotonin dynamics.Nat. Neurosci.24746752. 10.1038/s41593-021-00823-7

  • 305

    WangD.HeX.ZhaoZ.FengQ.LinR.SunY.et al (2015). Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons.Front. Neuroanat.9:40. 10.3389/fnana.2015.00040

  • 306

    WangD.ZhangZ.ChandaB.JacksonM. B. (2010). Improved probes for hybrid voltage sensor imaging.Biophys. J.9923552365. 10.1016/j.bpj.2010.07.037

  • 307

    WatanabeK.ChiuH.PfeifferB. D.WongA. M.HoopferE. D.RubinG. M.et al (2017). A Circuit Node that Integrates Convergent Input from Neuromodulatory and Social Behavior-Promoting Neurons to Control Aggression in Drosophila.Neuron951112.e1128.e. 10.1016/j.neuron.2017.08.017

  • 308

    WestonM.KasererT.WuA.MouravlevA.CarpenterJ. C.SnowballA.et al (2019). Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.Sci. Adv.5:eaaw1567. 10.1126/sciadv.aaw1567

  • 309

    WhissellP. D.TohyamaS.MartinL. J. (2016). The use of dreadds to deconstruct behavior.Front. Genet.7:70. 10.3389/fgene.2016.00070

  • 310

    WickershamI. R.FinkeS.ConzelmannK.-K.CallawayE. M. (2007). Retrograde neuronal tracing with a deletion-mutant rabies virus.Nat. Methods44749. 10.1038/nmeth999

  • 311

    WietekJ.BeltramoR.ScanzianiM.HegemannP.OertnerT. G.WiegertJ. S. (2015). An improved chloride-conducting channelrhodopsin for light-induced inhibition of neuronal activity in vivo.Sci. Rep.5:14807. 10.1038/srep14807

  • 312

    WietekJ.Rodriguez-RozadaS.TutasJ.TenediniF.GrimmC.OertnerT. G.et al (2017). Anion-conducting channelrhodopsins with tuned spectra and modified kinetics engineered for optogenetic manipulation of behavior.Sci. Rep.7:14957. 10.1038/s41598-017-14330-y

  • 313

    WindenK. D.OldhamM. C.MirnicsK.EbertP. J.SwanC. H.LevittP.et al (2009). The organization of the transcriptional network in specific neuronal classes.Mol. Syst. Biol.5:291. 10.1038/msb.2009.46

  • 314

    WojaczynskiG. J.EngelE. A.SterenK. E.EnquistL. W.Patrick CardJ. (2015). The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties.Brain Struct. Funct.22013951420. 10.1007/s00429-014-0733-9

  • 315

    WonS. M.SongE.ReederJ. T.RogersJ. A. (2020). Emerging modalities and implantable technologies for neuromodulation.Cell181115135. 10.1016/j.cell.2020.02.054

  • 316

    WuJ.AbdelfattahA. S.ZhouH.RuangkittisakulA.QianY.BallanyiK.et al (2018). Genetically Encoded Glutamate Indicators with Altered Color and Topology.ACS Chem. Biol.1318321837. 10.1021/acschembio.7b01085

  • 317

    XuX.HolmesT. C.LuoM.-H.BeierK. T.HorwitzG. D.ZhaoF.et al (2020). Viral Vectors for Neural Circuit Mapping and Recent Advances in Trans-synaptic Anterograde Tracers.Neuron10710291047. 10.1016/j.neuron.2020.07.010

  • 318

    YangH. H.St-PierreF. (2016). Genetically encoded voltage indicators: opportunities and challenges.J. Neurosci.3699779989. 10.1523/JNEUROSCI.1095-16.2016

  • 319

    YangS. J.AllenW. E.KauvarI.AndalmanA. S.YoungN. P.KimC. K.et al (2015). Extended field-of-view and increased-signal 3D holographic illumination with time-division multiplexing.Opt. Express233257332581. 10.1364/OE.23.032573

  • 320

    YangW.Carrillo-ReidL.BandoY.PeterkaD. S.YusteR. (2018). Simultaneous two-photon imaging and two-photon optogenetics of cortical circuits in three dimensions.eLife7:e32671. 10.7554/eLife.32671

  • 321

    YangW.YusteR. (2018). Holographic imaging and photostimulation of neural activity.Curr. Opin. Neurobiol.50211221.

  • 322

    YeH.FengB.WangC.SaitoK.YangY.IbrahimiL.et al (2022). An estrogen-sensitive hypothalamus-midbrain neural circuit controls thermogenesis and physical activity.Sci. Adv.8:eabk0185. 10.1126/sciadv.abk0185

  • 323

    YizharO.FennoL. E.DavidsonT. J.MogriM.DeisserothK. (2011). Optogenetics in neural systems.Neuron71934. 10.1016/j.neuron.2011.06.004

  • 324

    ZeiselA.Muñoz-ManchadoA. B.CodeluppiS.LönnerbergP.La MannoG.JuréusA.et al (2015). Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq.Science34711381142. 10.1126/science.aaa1934

  • 325

    ZemanickM. C.StrickP. L.DixR. D. (1991). Direction of transneuronal transport of herpes simplex virus 1 in the primate motor system is strain-dependent.Proc. Natl. Acad. Sci. U.S.A.8880488051. 10.1073/pnas.88.18.8048

  • 326

    ZengW.-B.JiangH.-F.GangY.-D.SongY.-G.ShenZ.-Z.YangH.et al (2017). Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain H129.Mol. Neurodegener.12:38. 10.1186/s13024-017-0179-7

  • 327

    ZhanC.ZhouJ.FengQ.ZhangJ.-E.LinS.BaoJ.et al (2013). Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively.J. Neurosci.3336243632. 10.1523/JNEUROSCI.2742-12.2013

  • 328

    ZhangL.LiangB.BarberaG.HawesS.ZhangY.StumpK.et al (2019). Miniscope GRIN Lens System for Calcium Imaging of Neuronal Activity from Deep Brain Structures in Behaving Animals.Curr. Protoc. Neurosci.86:e56. 10.1002/cpns.56

  • 329

    ZhaoY.ArakiS.WuJ.TeramotoT.ChangY.-F.NakanoM.et al (2011). An expanded palette of genetically encoded Ca2+ indicators.Science33318881891. 10.1126/science.1208592

  • 330

    ZhouP.ReimerJ.ZhouD.PasarkarA.KinsellaI.FroudarakisE.et al (2020). EASE: EM-Assisted Source Extraction from calcium imaging data.BioRxiv [preprint] 10.1101/2020.03.25.007468

  • 331

    ZhuC.JiangZ.XuY.CaiZ.-L.JiangQ.XuY.et al (2020). Profound and redundant functions of arcuate neurons in obesity development.Nat. Metab.2763774. 10.1038/s42255-020-0229-2

  • 332

    ZhuH.PleilK. E.UrbanD. J.MoyS. S.KashT. L.RothB. L. (2014). Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory.Neuropsychopharmacology3918801892. 10.1038/npp.2014.35

  • 333

    ZinggB.PengB.HuangJ.TaoH. W.ZhangL. I. (2020). Synaptic specificity and application of anterograde transsynaptic AAV for probing neural circuitry.J. Neurosci.4032503267. 10.1523/JNEUROSCI.2158-19.2020

  • 334

    ZongW.WuR.LiM.HuY.LiY.LiJ.et al (2017). Fast high-resolution miniature two-photon microscopy for brain imaging in freely behaving mice.Nat. Methods14713719. 10.1038/nmeth.4305

  • 335

    ZouP.ZhaoY.DouglassA. D.HochbaumD. R.BrinksD.WerleyC. A.et al (2014). Bright and fast multicoloured voltage reporters via electrochromic FRET.Nat. Commun.5:4625. 10.1038/ncomms5625

Summary

Keywords

neural circuit tracing, cell type-specific, viral genetic technology, calcium/voltage indicator imaging, neurotransmitter/biosensors, chemogenetics, optogenetics, targeted ablation

Citation

Swanson JL, Chin P-S, Romero JM, Srivastava S, Ortiz-Guzman J, Hunt PJ and Arenkiel BR (2022) Advancements in the Quest to Map, Monitor, and Manipulate Neural Circuitry. Front. Neural Circuits 16:886302. doi: 10.3389/fncir.2022.886302

Received

28 February 2022

Accepted

27 April 2022

Published

26 May 2022

Volume

16 - 2022

Edited by

Petr Tvrdik, University of Virginia, United States

Reviewed by

Ayumu Inutsuka, Jichi Medical University, Japan; Tommaso Patriarchi, University of Zurich, Switzerland

Updates

Copyright

*Correspondence: Benjamin R. Arenkiel,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics